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ABSTRACT
Characterizing the Role of HspB2 in Cardiac Metabolism and Muscle Structure
Using Yeast and Mammalian Systems
Jonathan Neubert
Department of Microbiology and Molecular Biology, BYU
Master of Science
HspB2 is a small heat shock protein encoded on human chromosome 11. Less than 1000 base
pairs away from HSPB2 and situated in a head-to-head orientation lies the gene encoding another
small heat shock protein, CRYAB. Because they are uncommonly close to one another they
share regulatory elements. In addition, they share protein homology as sHSPs, suggesting that
they perhaps perform similar functions. SHSPs such as HspB2 and CryAB are traditionally
thought to provide protective effects to cells in response to a variety of stress inducers. In
response to stress they form complexes around misfolded proteins or proteins in danger of
denaturation. HspB2 has been shown to exhibit protective effects during cellular stress and to
localize to the Z-line of skeletal muscle. It has also been implicated in cardiac energetics,
specifically in the production of ATP, however little is known about its molecular targets. Here I
report the use of yeast two-hybrid screening to uncover the molecular targets of HspB2. I also
detail the process by which the screens are performed as well as the verification steps, including
co-precipitation experiments in mammalian cells. Through these studies we identify many novel
binding partners of HspB2, including CryAB as well as multiple muscle and mitochondrial
proteins. Proteins discovered to bind to HspB2 include such proteins as actin and myosin,
enzymes catalyzing various steps of glycolysis and the electron transport chain, as well as
redox-, small heat shock protein-, kinase-, and electrolyte-related proteins, among others.
Studies of the binding partners of HspB2 in cardiac tissue will provide important information
clarifying the involvement of HspB2 in cardiac muscle maintenance and metabolism.

Keywords: small heat shock proteins, HSPB2, CRYAB, yeast two-hybrid,
coimmunoprecipitation
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CHAPTER ONE: Introduction, Background, Specific Aims Summary
Introduction: sHSPs

Researchers have identified HspB2 as one of eleven presently-known small heat shock proteins
(sHSPs) encoded in the human genome.2, 3 Typically functioning as protein chaperones, heat
shock proteins are primarily involved in protecting cells from a variety of stresses including
shock related to extreme heat or cold, oxidative/reductive stress, and heavy metal-induced
stress.4 Cellular stress often causes proteins to misfold or to unfold. Proteins in these
undesirable states bind to each other and form protein aggregates—nonfunctional protein
complexes. The occurrence of protein aggregation causes organ dysfunction such as in cataract
formation and amyloid fibril development leading to neurodegenerative diseases.5 In an ATPindependent manner, sHSPs form complexes around misfolded or unfolded proteins in order to
prevent protein aggregation.6-9 Members of the small heat shock protein family, while similar in
their general form and function, often exist in varying levels throughout the body, suggesting a
specific and unique function from one another. Since the discovery of HSPB2 in 1997
researchers have tried to deduce its functional role, leaving us with a presently incomplete
understanding of this small heat shock protein. In this chapter I will continue to provide an
introduction of the family of sHSPs and will then specifically focus on our current understanding
of HspB2, briefly reviewing various papers and focusing on its relationship with the heart.
Following an adequate introduction to sHSPs and necessary background about HspB2, I will
emphasize both the significance of HspB2 and that of our study.
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Morphologically, sHSPs share many similarities, yet present knowledge of their structure
remains incomplete. One reason for the lack of understanding is that none of the human sHSPs
have yet been crystallized, however we can gain understanding from crystal structure studies of
sHSPs found in Methanococcus jannaschii (HSP16.5), wheat (HSP16.2), and Taenia saginata
(TSP36).10-12 These studies shed light into heat shock protein fundamentals such as how heat
shock proteins oligomerize and function as chaperones. However, Basha et al. note that there is
no universal model to describe the structure, function, and mechanism of action of the sHSPs.13
On a general level, sHSPs are structurally characterized by low monomeric molecular mass (1543 kDa).14-16 While each of the sHSPs are of differing lengths they share a conserved alphacrystallin domain in their C-terminal regions.17-19 Hsp27 (HspB1) and HspB5 (CryAB or αβcrystallin) are among the most researched sHSPs. In a study of Hsp27, Lambert et al. suggest
that the alpha-crystallin domain of Hsp27 is functionally involved in Hsp27-Hsp27 interactions,
suggesting that this domain is involved in oligomerization.20 The N-terminal region contains
nonconserved sequences and commonly one or two regions rich in proline and phenylalanine
called WD/EPF motifs.21-23 Lambert et al. also show in the aforementioned study that the
WD/EPF region is involved in oligomerization in response to phosphorylation of certain amino
acid residues.20 The C-terminal region of the alpha crystallin domain contains a flexible tail
conferring solubility to the sHSPs and has been shown to regulate oligomerization .24, 25
From a molecular perspective HspB2 is the most divergent of the sHSP family, containing only
30% sequence identity to the other sHSPs (excluding HSPB11).26 Although the sequence of
HSPB2 is quite different than other sHSPs, it localizes to similar areas as several members of the
small heat shock protein family (see .1 1).27
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Protein

Alternate Name

Localization

HspB1

HSP27

Ubiquitous

HspB2

MKBP

Cardiac and Skeletal Muscle

HspB3

HspL27

Cardiac and Skeletal Muscle

HspB4

αA-crystallin

Eye Lens

HspB5

αB-crystallin

Ubiquitous

HspB6

Hsp20

Ubiquitous

HspB7

cvHSP

Cardiac and Skeletal Muscle

HspB8

Hsp22

Ubiquitous

HspB9

--

Testis

HspB10

ODF

Testis

HspB11

Hsp16.2

Ubiquitous

Table 1.1 SHSPs, their alternate names, and localizations in the human body. Adapted from Laskowska et al. 2010

sHSPs are generally expressed ubiquitously in the human body, although some are specific to
certain organs. Many, while expressed in various tissues, are found at higher levels in some
tissues than in others. HspB5 (αB-crystallin), for instance, is found throughout the body but it
has higher abundance in the heart and eye, making up approximately 50% of the protein mass in
the human lens.28 SHSPs that localize to specific parts of the body include HspB2, HspB3,
HspB4, HspB7, HspB9, and HspB10. While HspB2, HspB3, and HspB7 are expressed
ubiquitously, they are especially localized to cardiac and skeletal muscle.27 HspB9 and HspB10
are found solely in the testis.29, 30 Understanding localization to different areas of the body and,
more appropriately, the respective tissues and even the intercellular locations, will perhaps help
us better understand the function of each of the sHSPs.
3

Background: HspB2

In the following section I provide background information specific to HspB2 in a more-or-less
chronological manner, outlining key papers, experiments, and results that compose the current
knowledge in the field, and especially
include information that is pertinent to
deducing the role of HspB2. HspB2 was
first referred to as myotonic dystrophy
binding protein (MKBP) since it was
discovered bound to myotonic dystrophy
protein kinase (DMPK).31 It is more
properly known as HspB2, thus I will refer
to it as HspB2 regardless of what it was
termed in the original literature.15, 32, 33
As stated previously, HspB2 is one of
eleven known sHSPs and is primarily

Figure 1.1 Northern blot showing that HSPB2 localizes to the
heart and to skeletal muscle. Adapted from Suzuki et al. 1998.

expressed in the heart and skeletal muscle (see Table 1.1).31 Using the yeast two-hybrid
system—the same system we are using in our study—Suzuki et al. looked for binding partners of
DMPK. DMPK was of particular interest because certain DMPK mutations cause myotonic
dystrophy, an autosomal dominant disease manifesting various symptoms including myotonia
and muscle weakness. Patients also often show cardiac conduction defects, cataracts, atrophy of
the testicles/ovaries, diabetes, and mental dysfunction as a result of the disease.34 The mutation
responsible for the disease was located within DMPK, however it appeared to be in an
4

untranslated region of the gene, meaning that DMPK should function normally when
expressed.35-37 In hopes of understanding the role of DMPK, Suzuki et al. searched for binding
partners using a cDNA library as the prey protein and DMPK as the bait in a traditionally yeast
two-hybrid screen (Chapter 2). From this screen they uncovered HspB2 bound to DMPK. They
also noted that HspB2 formed a complex with itself but not with several of the other sHSPs,
including CryAB. Additionally they also noted that HspB2 localized to sarcomeric Z-lines and
hypothesized that it may provide protection to the proteins found in this region. Unpublished
data by Suzuki et al. reports that HSPB2 was upregulated in stretched neonatal mouse
cardiomyocytes, also suggesting an involvement in muscle structure maintenance. This early
look at HspB2 was surprisingly not the first discovery of the protein. Another lab a year earlier
discovered a novel heat shock protein-encoding gene while investigating the region upstream of
CRYAB.32 The protein they found was identical to HspB2.31
Upstream of CRYAB, Iwaki et al. discovered another sHSP encoded by the chromosome.32
They found that HSPB2 and CRYAB are situated in a head-to-head fashion on human
chromosome 11, only 958bp from each other.32 In this orientation they are transcribed in
opposite directions. Iwaki et al. noted that, traditionally, genes transcribed in this manner share
physiological and structural similarities and share regulatory elements.38-41 Particularly
interesting to their study is the fact that northern blot analysis of various rat tissues showed
HspB2 localization to heart and femoral muscle tissues (see Figure 1.2). In the same northern
blot experiment they found that CryAB also localizes to heart and femoral muscle, but is
additionally expressed at a high level in lens tissue. They also noted that levels of HSPB2
expression were far less than that of CRYAB in all tissues where the proteins were both present.
If, indeed, CRYAB and HSPB2 share regulatory elements, this finding begs the question of how
5

and why they are differentially expressed in various tissues. In contrast to differential
expression, similarities may also exist between them; they noted that HSPB2 and CRYAB may
share similar pathologic roles such as in mitochondrial myopathies of the muscle.42, 43
Yoshida et al. furthered the investigation of the physiologic and perhaps pathogenic role of
HspB2 in a study identifying the intracellular locations of HspB2 in the ischemic heart.44 They
measured HspB2 quantity for three fractions of the cell: the nuclear-myofibril, membrane, and
cytosolic fractions and found that, the longer the heart was under ischemic conditions, an
increased amount of HspB2 was found in the nuclear-myofibril and a decreased amount found in
the cytosolic fractions. The
membrane fraction did not
yield any HspB2 detection.
In the same study they also
noted that Hsp27
translocates in a similar
manner to the nuclearmyofibril fraction, perhaps
suggesting similar roles for
the two sHSPs. Further
Figure 1.2. Northern blot of various rat tissue. 1, lens; 2, femoral muscle; 3, heart; immunohistochemical
4, kidney; 5, brain; 6, thymus; 7, liver; 8, U-373MG cells; 9, HeLa cells. U-373MG
is a glioblastoma/astrocytoma cell line.1 Note that although CRYAB and HSPB2
observation showed that
share regulatory elements, CRYAB localizes to the eye lens while HSPB2 does not.
Adapted from Yoshida et al., 1997.

both HspB2 and Hsp27

translocate to the myofibrillar Z-line. Yoshida et al. also noted that there was no increase in
phosphorylation of HspB2 in the ischemic heart and that translocation occurs regardless of
6

whether cells were exposed to inhibitors of MAP kinase and protein kinase C. This suggests that
perhaps the translocation of HspB2 is driven by an alternate phosphorylation-independent
pathway. This study by Yoshida et al. is important because it points out similar roles for HspB2
and other sHSPs. CryAB, for instance, was also shown to translocate to myofibrillar Z-lines in
response to ischemia.45, 46
In a collaborative work with Yoshida and others, Shama et al. showed increased levels of HspB2
and Hsp27 in neonatal rat heart myocardium.47 These levels peaked one week after birth then
decrease over the following weeks. As a comparison they also note that human levels of HspB2
in the heart follow a similar pattern, peaking between two and 11 months and remaining low in
the following months and years. Also significant to the study by Shama et al. is the discovery
that HspB2 and desmin colocalize to the myofibrillar Z-line. Desmin is an intermediate filament
present in cardiac, skeletal, and smooth muscle and mutations in desmin have been shown to
cause multiple muscle problems, including cardiomyopathy.48-50 Additionally, Shama et al.
showed that HspB2 also localizes to cardiac intercalated discs by immunofluorescent
microscopy. In their discussion as to why levels of HspB2 are found to be increased in neonatal
heart they note that during birth the heart goes through a period of ischemia followed by
reperfusion as the rat begins to breathe on its own. This process introduces the heart to oxidative
stress and could identify the need for increased sHSP expression.51, 52 They also suggest that
since in this study they observed high cytosolic levels of HspB2, perhaps the protein is involved
in protecting actin or other cytosolic proteins that proliferate during the initial stages of life.
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Aside from providing an overview of the five sHSPs known at the time, Sugiyama et al. reported
the finding of an additional small heat shock protein, HspB3.53 In a northern blot they showed
that HSPB3 is also expressed mostly in the heart and in skeletal muscle (see Figure 1.3).
Analysis by western blot showed that the new sHSP was found in heart and prostate tissues (see
Figure 1.4). They also showed that HspB2 was found in rat heart and skeletal muscle tissues, in
addition to a small
amount found in
rat thymus and
colon tissues. Of
all the other
proteins analyzed,
the researchers
remarked that
HspB2 and HspB3
show the most
similar distribution

Figure 1.3. Northern blot showing the various expression levels in adult human tissue
types. Tissues are as follows: 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6, skeletal
muscle; 7, kidney; 8, pancreas; 9, spleen; 10, thymus; 11, prostate; 12, testis; 13, ovary;
14, intestine; 15, colon; 16, blood. Adapted from Sugiyama et al., 2000.

patterns to each
other. They also demonstrated that both HspB2 and HspB3 are induced at a similar time during
a late phase of muscle differentiation. Notable is the fact that their expression was not induced
by stress but by the myogenic factor MyoD. This provides evidence that sHSPs are not solely
involved in stress-management but may also contribute to normal cellular differentiation and
development. Continuing to develop the possible relationship between HspB2 and HspB3,
8

Sugiyama et al. provide evidence of protein-protein interaction via the yeast two-hybrid.
Importantly, they also report that HspB2 binds to HspB6, HspB3, but not CryAB. This was
confirmation of a previous finding.31 Sugiyama et al. further support the idea that sHSPs have
differential function as they reported that several other sHSPs localize to cellular myotubes while
HspB2 and HspB3 do not. In the final experiment of the paper, researchers studied whether
these six sHSPs were induced by heat shock. They reported that while many sHSP’s were,
HspB2, HspB3, and HspB6 were not, also in part a confirmation of previous data.31 They
conclude that in order to identify the function of individual sHSPs we must understand their
oligomerization
states and how they
translocate to the
insoluble cellular
fraction in the
presence of certain
stresses.
In addition to
understanding the
binding partners of
sHSPs it is
important to
understand the

Figure 1.4. Comparison of expression levels for various sHSPs for human adult tissues.
Note that HSPB5 is ubiquitously expressed, as shown by the extended exposure in the
last row. Tissues are as follows: 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6,
skeletal muscle; 7, kidney; 8, pancreas; 9, spleen; 10, thymus; 11, prostate; 12, testis;
13, ovary; 14, intestine; 15, colon; 16, blood. Adapted from Sugiyama et al., 2000.

location of sHSPs within the cell. Nakagawa et al. continued to shed light on the important
subject as they show where HspB2 localizes within the cell.33 They chose cell lines KNS-81,
9

C2C12, and NIH3T3—cells derived from human malignant glioma, mouse myoblast cells, and
mouse fibroblasts, respectively—as their model for subcellular localization. Using
immunofluorescence microscopy and staining with a mitochondrial marker along with antiHsp60 and anti-HspB2 fluorescent antibodies, they showed that HspB2 localized to the
mitochondria of KNS-81 cells (see Figure 1.5). They noticed general fluorescence around the

Figure 1.5. HSPB2 localizes to the outer mitochondrial membrane. Immunofluorescence imaging shows noncardiac KNS-81 cells treated with 1μM colchicine at 37oC for two hours. A shows staining with anti-HSPB2
antibody; B shows staining with anti-human mitochondrial monoclonal antibody; C is the merged image showing
colocalization of the two sHSPS. Adapted from Nakagawa et al., 2001.

mitochondria with patches of greater fluorescence within this background. To determine if these
were showing HspB2 bunching around microtubules, they treated cells with colchicine, a
microtubule depolymerizing reagent, and the clusters remained, suggesting mitochondrial
association. To study the localization to the mitochondria more specifically Nakagawa et al.
took the mitochondrial fraction and concluded that HspB2 most likely attaches loosely to the
outer mitochondrial membrane rather than being transported inside the mitochondria, although
they do not completely rule out the possibility. Other sHSPs locate to the mitochondrial matrix
in other organisms, but there is no known human sHSP possessing a targeting signal specific to
the mitochondrial matrix.54-56 Importantly, Nakagawa et al. also note that exposure to increased
heat (42OC) prompted a greater level of HspB2 localization to the mitochondria. They
demonstrated that cells constitutively expressing HSPB2 lived through periods of heat shock that
10

were otherwise lethal to cells not expressing the sHSP. Interestingly, they also showed by
northern blot that HSPB2 expression is favored more in slow-twitch muscle than in fast-twitch.
They report that these levels coincide with levels of mitochondria in the different types of muscle
cells, slow-twitch muscles having more mitochondria. A role in mitochondrial maintenance
would not be unfounded for sHSPs since sHSPs have been shown to lend a protective role to
NADH ubiquinone oxidoreductase during cellular stress.57 In another study, Hsp27 associated
with the mitochondrial membrane interacted with cytochrome c oxidase in apoptotic pathways,
negatively regulating cell death.58 In conclusion Nakagawa et al. state that to discover the
function of HspB2, including any mitochondrial role, we must uncover its binding partners in
the cell.33
Departing from localization and binding studies, Morrison et al. utilized a recently developed
knockout (KO) mouse model for HSPB2 and CRYAB.59 As discussed previously, CryAB is
another small heat shock protein that is located nearby and shares a promoter region with
HspB2.32 In order to identify the function of sHSPs we must look at phenotypes following gene
deletion. Unfortunately, in the first mouse models the HSPB2 gene deletion included disruption
of the promoter region of HSPB2, likewise disrupting the promoter for CRYAB. Although this
mouse model was imperfect at showing the individual sHSP functions of HspB2 and CryAB, it
was the best model available at the time. Even though the authors could not show individual
functions, they hoped to demonstrate the importance of these two sHSPs in cardiac development,
structure, and function.59 To begin to understand the importance of these sHSPs, Morrison et al.
observed life span of wild type (WT) and knockout (KO) mice. They observed that KO mice
had similar survival rates through 10 months, after which the KO mice survival rates took a steep
decline (see Figure 1.6). The hearts of the deceased mice appeared normal, and they report that
11

their deaths were most likely related to malnourishment.16 Although the hearts were actually of
greater mass in the KO mice in comparison to their body weight, they discovered that this was
not due to hypertrophy, but rather because the KO mice had a decreased weight. Surprisingly,
the KO mice also had normal heart morphology at the microscopic level, showing the same
organization of
myofibrils and
sarcomeres as found in
WT mice. Moving into
functional studies, they
did not find a
significant difference
between WT and KO
Figure 1.6. Percent survival rates for wild type mice and those without HSPB2 or
CRYAB (KO). *, #, and † denote significance compared to wild type mice. Arrow
denotes 10 month mark decline. Adapted from Morrison et al. 2004.

hearts using
echocardiography,

except for increased left ventricular contractility in KO mice. After subjecting the hearts to
ischemia/reperfusion (periods of restricted blood flow followed by periods of resumed flow),
they found that KO mice had a decreased recovery of contractility following the stress. Morrison
et al. also observed greater levels of apoptosis and necrosis among KO mouse hearts following
ischemia/reperfusion.
Reactive oxygen species form during periods of reperfusion and Morrison et al. hypothesized
that during these times sHSPs may play an important protective role to the cells and tissues.
Indeed, previous research shows that CRYAB overexpression protected the heart during periods
of ischemia/reperfusion.60-62 Additionally, Morrison et al. report that levels of glutathione
12

(GSH), a protective molecule that neutralizes reactive oxygen species, were lower in the KO
mice, suggesting a potential role of the sHSPs regulating its production.63 In short, this study
helps identify the protective role of two sHSPs in the heart, however due to the lack of a mouse
with either gene knocked out alone, we are unable to deduce if the effects are due to one gene or
another or to some kind of relationship between the two.
Benjamin et al. suggest that the lack of structural or histological abnormalities in KO hearts may
be due to redundancy among the sHSPs or that it may show a need for more sensitive detection
of phenotypes.15 In addition, they found beneficial phenotypes of the combined HSPB2 and
CRYAB deletion mice. In light of the report by Morrison et al., these findings are controversial,
however Benjamin et al. make different observations, so we can discount neither study. Firstly,
Benjamin et al. observed cardiac morphology between WT and KO mice hearts and found no
tissue abnormalities in the KO hearts, agreeing with previous data.16, 59 Secondly, they report
that KO hearts show a lesser infarct size in response to ischemia/reperfusion when compared to
WT hearts. They also observed that in the KO mice, levels of some of the other heat shock
proteins remained the same while others were lower than in WT. HspB1, for instance, was
decreased in the cytosolic fraction and increased in the nuclear/pellet fraction compared to WT.
This finding supports the idea that sHSPs work together to fill the needs of the cell during stress,
and perhaps some can fulfill the need when others are absent. Very interesting to our current
study is an observation regarding mitochondrial respiration. They report that mitochondria in
KO mice respire at a much lower level than in WT and that significantly lower amounts of ATP
are produced compared to WT (see Figure 1.7). Although we cannot be certain whether HspB2
or CryAB is responsible—or if they act in concert—this observation supports the idea of a
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relationship between sHSPs and cardiac metabolism, and is the first paper to suggest such a
relationship.
A similar study by Golenhofen et al. specifically looked at papillary muscles isolated from mice
without HSPB2 and CRYAB.64
Similar to Morrison et al., they
observed increased rates of
mortality and decreased body
weight in mice lacking HSPB2 and
CRYAB. They also observed that
between 35 and 40 weeks of age
the mice developed a hunchback
phenotype, signifying degeneration
of skeletal muscle. Because of this
Figure 1.7. ATP production rates in cardiac fibers for wildtype (WT)
and double knockout (DKO) mice. Adapted from Benjamin et al.
2006.

particular phenotype and for the
fact that increasing numbers of

mice died as they approached 40 weeks, Golenhofen et al. selected papillary muscles from these
aged hearts. They first measured contractility of the papillary muscles and found no significant
difference between the WT and KO hearts. In addition, they also note support for the lack of
significant difference by the fact that there is no apparent histological difference between the two
mice strains. However, they observed a marked difference between the two when placed in
solution simulating ischemia reperfusion. KO hearts contracted quicker and possessed a higher
resting tension, but there was less affect on twitch force. After reperfusion, hearts from the two
groups recovered in similar manners. They discuss several possible mechanisms for the
14

increased resting tension in KO mouse hearts and favor a mechanism in which HspB2 and/or
CryAB acts on the elastic titin filament system.
Of particular interest to our research are studies performed by Kadono et al. because it relates
HSPB2 and CRYAB to metabolism.65 Using the mouse model lacking HSPB2 and CRYAB,
they attempted to provide an explanation for increased apoptosis and necrosis in response to
ischemia and reperfusion.59 They first assessed levels of Ca2+ because increased calcium
concentration can lead to a greater extent of injury due to ischemia/reperfusion.66 Observing
cytosolic calcium levels, Kadono et al. showed that KO myocytes uptake less calcium than WT
myocytes when submitted to simulated ischemia. Later experiments further established that
mitochondrial levels of calcium increased in KO myocytes as compared to wild type and showed
that these organelles took in calcium from the cytosol, an important method of cytosolic calcium
regulation (see Figure 1.8).67, 68 Additionally, they determined that sHSPs may regulate nitric
oxide production, a known regulator of mitochondrial Ca2+ uptake.69, 70 Increased calcium
uptake, along with increased ROS production, is a characteristic of mitochondria permeability
transition, a contributor of the damage due to ischemia/reperfusion.71 Measuring myocyte
contracture (a method of measuring mitochondria permeability transition) while manually
opening the permeability transition pore, Kadono et al. found that the KO mice developed
mitochondria permeability transition sooner than WT myocytes.72, 73 In short, the research
performed by Kadono et al. suggests that the lack of HspB2 and/or CryAB preconditions
myocytes for damage due to increased calcium sequestration by the mitochondria, a known step
in the inducement of mitochondria permeability transition. This may provide an answer to why
there is increased apoptosis and necrosis among these cells during ischemia/reperfusion, as noted
previously.
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In an attempt to provide a
better understanding of the
individual function of HspB2,
separate from that of CryAB,
Pinz et al. transgenically
Figure 1.8. Increased fluorescence in mice lacking HSPB2 and CRYAB
shows that mitochondria uptake of calcium is greater in DKO mice.
Fluorescence is caused by the mitochondrial calcium indicator Rhod-2.
The experiment was conducted where all Rhod-2 was intramitochondrial.
Adapted from Kadono et al. 2006.

expressed CRYAB in the
mouse model lacking both
HSPB2 and CRYAB.74 We

note that, while this offers valuable insights, they show by western blot that the transgenic
expression of CRYAB far exceeds the level of CRYAB in the WT mice. For this reason, we
must be careful about how we view this data because overexpression of CRYAB is known to
have phenotypic effects.75 They observed possible functions for HSPB2 by comparing several
strains of mice—WT, double KO, WT mice with transgenic expression of CRYAB, and mice
with the double KO and transgenic expression of CRYAB. After a period of ischemia, hearts
that did not contain HSPB2 lost significantly more ATP and had a slower recovery than hearts
with HSPB2 intact (see Figure 1.9). This may be because hearts lacking HSPB2 also have a
lower contractile reserve than the controls, suggesting that HspB2 is necessary for an increased
workload on the heart. In addition, they found that hearts lacking HSPB2 are unable to properly
couple energy from ATP hydrolysis, leading to energy defects in the cell. While their
experiment is imperfect in its “deletion” of CRYAB, it does contribute potentially valuable
information that agrees with data relating HspB2 to mitochondrial function.
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In addition to
relationships with
muscle and
metabolism, Oshita
et al. report that
HspB2 confers an
anti-apoptotic
quality in a certain
line of breast cancer

Figure 1.9. ATP levels in the heart after ischemia (white bars) and after
reperfusion (black bars). Adapted from Pinz et al., 2008.

cells.76 This is
particularly important because removal of HspB2 seems to increase levels of apoptosis and
necrosis.59 In this paper Oshita et al. suggest mechanisms for its ability to confer resistance to
apoptosis. Working in a breast cancer cell line ectopically expressing HSPB2 they show that
HspB2 inhibits the extrinsic apoptotic pathways initiated by TNF-related apoptosis-inducing
Ligand (TRAIL) and TNF-α. By so doing, it inhibits downstream events leading to eventual
apoptosis.
While researchers have done much to discover the function of HspB2, current models are not
able to explain its precise role in the cell. They have shown, however, that it has possible
relation to muscle and mitochondrial function in the heart,.. Furthermore, unpublished data from
a yeast two-hybrid screen reports an interaction between R120G CryAB—a mutated form of the
small heat shock protein CryAB conferring cardiomyopathy—and HspB2 (Julianne Grose,
unpublished results). As stated before, in order to gain a more complete understanding of the
function of HspB2 we must find out what it binds.33 By performing an exhaustive screen for
17

proteins in the heart that interact with HspB2 we hope to better understand the role played by
HspB2 in cardiac metabolism and muscle maintenance.
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Specific Aims: A Summary
SHSPs play an important role in maintaining intracellular proteins by providing protective
effects to the cell, mainly through the maintenance of protein folding during times of stress.
Although HspB2 is less understood that other sHSPs it has been implicated in the maintenance of
energy production and involvement in muscle function. Little is known about the mechanisms of
its involvement in these capacities. A study to identify HspB2 substrates will greatly contribute
to the current knowledge on HspB2 and on the general role of sHSPs within the cell.
Aim One: Discover and identify putative HspB2 binding partners using the yeast twohybrid.
We will identify putative binding partners in yeast through the yeast two-hybrid screen using
HspB2 as our “bait” and a cDNA library from human heart as our “prey”. We screened over 20
million library plasmids from which approximately 9,000 interactions were identified, 600 of
which were sequenced. The yeast two-hybrid screen may identify key HspB2 substrates
underlying its cellular function.
Aim Two: Verify putative HspB2 binding partners in yeast through the HspB2 dependency
test.
The sensitivity of the yeast two-hybrid can potentially lead to high false-positive rates. Thus,
proteins identified as putative HspB2:human heart interactions in Aim One will be tested for
their dependency on HspB2 . Briefly, plasmids expressing the proteins identified in Aim One
will be purified and transformed into naïve yeast with our without HSPB2, and scored for their
ability to activate the yeast two-hybrid system. This Aim will provide a second proof that the
interaction is occurring in yeast before confirmation in mammalian cells (Aim Three).
Aim Three: Verify putative HspB2 binding partners in mammalian cells (HEK 293).
Although the yeast two-hybrid system we use in the fulfillment of the first two aims is very
sensitive and false positive incidence is low, we must verify interaction in mammalian cells. We
used HEK 293 cells to verify two key interactions discovered in Aims One and Two.
To our knowledge, a comprehensive yeast two-hybrid screen has never been performed for any
of the sHSPs. Study into the molecular binding partners of HspB2 through yeast two-hybrid
with a cDNA library will provide valuable insight into an understudied member of the sHSP
family.
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CHAPTER TWO: Aim One: Discover and identify putative HspB2 binding partners using
the yeast two-hybrid screen.
Introduction and Methods

Saccharomyces cerevisiae serves as an excellent model organism for identifying protein-protein
interactions through the yeast two-hybrid method. Until Fields and Song developed the yeast
two-hybrid method in 1989, researchers had to use such biochemical tools as crosslinking, coimmunoprecipitation, and co-fractionation by chromatography to detect protein-protein
interactions.1 Chien et al remark that this novel method allows researchers to verify interaction
without the preparation or purchase of expensive antibodies, and does not require the purification
of protein for biochemical analysis.2 Although reviewers of the first grant application of what
was to become the two-hybrid method did not believe the technology was feasible, Fields said
that he and others began work on the method because of its beauty and elegance.3 The yeast
two-hybrid has been refined over the years although the fundamental science behind the method
is the same.
The yeast two-hybrid method relies on the ability to split the GAL4 transcription factor into two
separate units that, when brought together again, function as a transcriptional activator (see
Figure 2.1). The GAL4 transcriptional activator binds to specific sequences of DNA upstream a
series of genes necessary for galactose utilization.1, 4 The activator itself is composed of two
main domains—a DNA-binding domain located at the N-terminus of the protein and an
activation domain at the C- terminus.1 The N-terminus contains a nuclear localization sequence
that allows its entry into the nucleus, as well as a domain that binds to specific sequences of
DNA; the C-terminal domain of the GAL4 transcriptional activator contains acidic regions and is
24

required to initiate
transcription.5-7 These
two domains are
essential for
transcription to occur.
In essence, two
“hybrid” proteins are
Figure 2.1. The yeast two-hybrid system works because the Gal-4 transcriptional
activator can be split into the activating domain and the DNA-binding domain, yet still
remain functional when brought back into close proximity to each other.

created with one
possessing the GAL4

DNA-binding domain (the “bait”) and another protein or library of proteins possessing the GAL4
activating domain (the “prey”). Due to their close proximity to one another, the DNA-binding
and activating domains initiate transcription when the hybrid proteins interact with one another
(see Figure 2.2). Transcription of various reporter genes allows for detection of these
interactions.

Figure 2.2 The yeast two-hybrid system for detection of protein-protein interactions. Two hybrid proteins are
created: the bait protein is fused to the Gal-4 DNA binding domain and the prey protein is fused to the Gal-4
activating domain. Interaction between the bait and prey proteins brings the activating domain and binding domain
of the Gal-4 transcriptional activator into proximity, allowing the recruitment of RNA polymerase and transcription
of the reporter gene.
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Use of the yeast two-hybrid model of detecting protein-protein interactions has historically
experienced issues with false-positives. Recent advances, however, have developed the yeast
two-hybrid system into a sensitive and reliable method for detecting such interactions. For our
yeast two-hybrid screen we are using the Matchmaker™ Gold Yeast Two-Hybrid system
developed by Clontech Laboratories, Inc..8 The Matchmaker™ system utilizes four reporter
genes (AUR1-C, HIS3, ADE2, and MEL1) situated on various yeast chromosomes. When
expressed in yeast, AUR1-C confers resistance to Aureobasidin A, a drug toxic to yeast. The
HIS3 gene allows the yeast to synthesize histidine, an essential amino acid, permitting it to
grown on media lacking histidine (-His). The ADE2 marker allows Matchmaker™ Gold yeast to
synthesize adenine, a necessary nucleotide, which permits the yeast to grow on media lacking
adenine (-Ade). MEL1 encodes α-galactosidase, which, in the presence of substrate X-α-Gal,
turns the yeast colonies blue. Each reporter gene is controlled by one of three unrelated GAL4
promoters, the G1, G2, and M1 promoters. Except for the 17-nucleotide sequence bound by the
GAL4 DNA-binding domain, each promoter is very different.9, 10 Three of the four reporter
genes must be expressed in order for growth to occur on selective media. If a certain protein
initiates transcription independently—without the GAL4 activating and DNA-binding
domains—it would be highly unlikely to do so at the other two promoters as well, due to their
different sequences. Thus, this system has a very low false positive rate; a less than 5-10% false
positive rate is common for most screens (Clontech, personal communication).
The yeast two-hybrid system affords researchers two abilities: to study putative interactions as
well as to perform a screen on a library of proteins in order to find protein-protein interactions.2
We are utilizing the yeast two-hybrid in both capacities, as outlined in Specific Aims One and
Two. We first perform a screen on a library of proteins (Aim One). To perform such a screen,
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we utilize certain “bait” and “prey” proteins as briefly introduced above. In our screen, HspB2
serves as the bait protein. The bait protein is a hybrid protein fused to the GAL4 DNA-binding
domain. The constitutively active, medium strength ADH1 promoter on pGBKT7 controls
expression of the gene encoding the hybrid protein. Also notable is the tryptophan biosynthesis
gene, TRP1, found in the plasmid. When this plasmid is transformed into yeast, the yeast
expresses the TRP1 gene, allowing the yeast to grow on selective media lacking tryptophan (-Trp
media). Transcription and then translation of HspB2 is coupled to transcription and translation
of the GAL4 DNA-binding domain to create the hybrid fusion protein, a single polypeptide chain
(HSPB2:GAL4 DNA-binding domain). The second hybrid protein—the prey protein—is created
from a library of human cDNA fragments made available by Clontech as a “Mate and Plate”
library. The necessary mRNA was recovered from three male hearts aged 33, 55, and 55 years of
age whose cause of death was trauma. The mate and plate library comes pre-cloned into the
pGADT7 vector. This plasmid, different from pGBKT7, contains LEU2, a leucine biosynthesis
gene, allowing the yeast to grow on media lacking leucine (-Leu media).
Yeast exist in haploid form as one of two mating types, a and α. A and α yeast containing either
bait or prey plasmids are mated, creating new diploid cells that contain both plasmids. To select
for both plasmids, yeast are grown in minimal SD media (synthetic dextrose) lacking the
essential amino acids leucine and tryptophan (-Leu-Trp). Cells that have not undergone proper
mating lack the pair of plasmids that allow for growth in the selective media. Growth of the
yeast on SD-Leu-Trp with Aureobasidin A selects for potential protein-protein interactions. At a
molecular level, if bait and prey proteins interact, the fused DNA-binding and activating domains
will be in adequate proximity to allow transcription of the reporter genes. If they grow on media
positive for Aureobasidin A, they are expressing the AUR1-C reporter gene. The compound X27

α-Gal is also added since blue colonies on media containing X-α-Gal denote colonies
expressing the MEL1 reporter (α-galactosidase), a second reporter. Hypothetically, however,
these may not be true protein-protein interactions because it is possible that the prey is able to
initiate transcription of both reporter genes without interacting with the bait. Thus, further
testing is necessary on media lacking three amino acids and one essential nucleotide (SD-LeuTrp-His-Ade), termed quadruple dropout media, because it lacks four essential elements
necessary for growth and selects for the expression of two other Gal4-regulated promoters. Note
that we do not select for all reporter genes at the same time because it stresses the yeast
detrimentally. The selection of yeast in this manner allows us to retain our bait and prey
plasmids by always using plates lacking leucine and tryptophan as well as selecting for the
various reporter genes as detailed above. Since it is highly unlikely that a protein can activate
transcription of all four reporter genes (three promoters) by binding to a GAL4 promoter and
recruiting RNA polymerase, we screen very stringently for false-positives.
Our basic method was to select yeast colonies from the mated plates SD-Leu-Trp+Aureobasidin
and patch them to SD-Leu-Trp-His-Ade+X-α-Gal plates divided into a 91-square grid (see
Figure 2.3). Each mated -Leu-Trp+Aureobasidin plate contains approximately 1200 colonies,
giving us approximately 10-15 91-square grid patch plates per mated plate. Each plate is given a
unique letter and number as means of identification and all information is recorded on an Excel
spreadsheet. All of our colonies turned blue when grown on X-α-gal plates, so we stopped the
use of this substrate in the plates after their initial isolation. We also noticed decreased viability
of yeast on plates containing X-α-gal after storing at 4’C.
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Each colony
growing on
selective media
is a potential
interaction
between hybrid
proteins. To
Figure 2.3. Yeast two-hybrid plates. Plate A is the initial mated plate (SD-LeuTrp+Aureobasidin). Each individual colony signifies a putative interaction between HspB2
identify the
and a human heart protein from a cDNA library. Colonies were chosen and patched onto a 91grid plate (B) made of SD-Leu-Trp-His-Ade+Aureobasidin or +X-α-Gal.

target protein

encoded by the prey plasmid we must seqeunce the insert on the plasmid. Colony PCR is
performed by simple lyticase treatment as detailed in the appendix. Briefly, we select a small
streak of cells from each of the gridded squares and treat with lyticase, which degrades the yeast
cell wall, followed by a period of boiling which releases the DNA into solution. The tubes are
briefly centrifuged to separate cell debris from supernate and a small amount of supernate is used
as template DNA in PCR amplification. The primers used in the PCR reaction anneal to portions
flanking the multiple cloning site of the pGADT7 plasmid, thus amplifying the gene from the
human heart library. Following PCR, samples are run on an agarose gel electrophoresis
apparatus in order to determine PCR product size. Band sizes are recorded and correspond to
each colony. We typically see a very diverse assortment of band sizes indicating many different
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binding partners (see Figure 2.4).

Figure 2.4. PCR band sizes for prey plasmid inserts. Typically a wide assortment of band sizes is seen. Note the
occasional double banding (sample 28). This most likely occurs from accidentally patching two colonies from the
mated plate to the 91-grid repatch plate.

Occasionally, double banding occurs in electrophoresis which may be due to accidentally
picking two colonies when patching from the mated plates. Clear, bright single bands are sent for
sequencing at the BYU Sequencing Center and identification of genes is performed using the
BLAST alignment tool provided by NCBI.11 We recorded each gene into the Excel database
specific to each plate and colony. Exhaustive attention to detail in recording information is
required in order to keep the results of each colony easily accessible.
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Results
Introduction

From this library screen we observed approximately 24 million matings (see Table 2.1).
Initial plating onto synthetic glucose media lacking, leucine, tryptophan, and including
Aureobasidin A (AbA) (SD-Leu-Trp+AbA), yielded approximately 10,000 colonies.
Restreaking onto synthetic glucose media lacking leucine, tryptophan, histidine, and adenine
(SD-Leu-Trp-His-Ade), yielded approximately 9,130 colonies.
Summary of HSPB2 Screen
Bait

No. of Matings

SD-Leu-Trp+AbA

Patch SD-LeuTrp-Ade

Currently
Sequenced

No. of unique
protein hits

HspB2

24, 200,000

~10,000

~9,130

~593

206

Table 2.1 Summary of the HspB2 yeast two-hybrid screen. Units are in number of colonies.

Thus, we estimate that HspB2 binds to approximately one of every 2,000 clones in the library.
We have currently sequenced approximately 600 samples and have recorded approximately two
hundred unique hits in the protein library. Of these hits, approximately 54 of these proteins are
our “high confidence hits” in that they have been hit two or more times, with some being hit over
100 times. Note, however, that the number of times a particular protein is hit may not reflect the
strength or importance of interaction as much as it reflects the abundance in the library.
These 54 unique proteins account for 383 of the ~600 sequenced putative interactions (see Table
2.2). The other proteins have only been hit once; although many are of interest, they are less
reliable as a single hit. Of these 54 protein-encoding genes, we observe that a large percentage
of them relate to muscular and mitochondrial function (see Table 2.2). Other genes encode
proteins involved in electrolyte-related activity, phosphorylation (kinases), maintenance of the
cellular redox state, assistance in stress (sHSPs), and many other proteins falling into various
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categories. Understanding the significance of these hits from the screen relies on our knowledge
of their various functions in the cell. Below I provide a brief synopses of the different functions
known for the genes identified in our screen. I briefly present information regarding some of
their pathogenic roles, but a more detailed discussion of the significance of the hits is provided in
the discussion. I first cover muscle proteins, then mitochondrial, followed by electrolyte-related,
kinases, redox-related, small heat shock proteins, and lastly I address the list of varied proteins
found in the “other” category. It is of note that our largest number of hits are specific
mitochondrial and muscle proteins, known pathways affected by HSPB2 deletion.

Muscle

Approximately 50 hits from the yeast two-hybrid screen are to genes encoding muscle-related
proteins. A list of the gene abbreviations, full names, and functions follows the gene
descriptions (see Table 2.2). Muscles are highly structured and rely on a vast network of
interacting proteins to maintain form and function. The proteins we hit in the screen fulfill
contractile, regulatory, and structural roles in the sarcomere.12
By way of introduction, skeletal muscle is organized into several groups, beginning with the
whole muscle (see Figure 2.5). Whole muscle is comprised of fasiculi—groupings of muscle
fibers. Muscle fibers are also known as muscle cells. Within each muscle cell are many
myofibrils—elements that extend the length of the muscle cell. Within the myofibrils we
observe a network of cytoskeletal elements called the thick and thin filaments.13, 14 Under the
microscope, the myofibrils appear striated as a result of the overlapping thin and thick filaments
(see Figure 2.6). Thin filaments anchor to the Z-line and the space from Z-line to Z-line is
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known as the sarcomere.
The sarcomere is the
functional unit of muscle
and is responsible for the
contraction of muscle.13, 14
Many proteins compose
the sarcomere, and the
results discussed below
describe the 14 muscle
Figure 2.5.Composition of skeletal muscle. Whole muscle is made of fasiculi,
which are composed of muscle fibers (muscle cells). Myofibrils, made partially
of actin and myosin filaments, help make up the components of the muscle
fibers. http://www.wellcome.ac.uk/Education-resources/Teaching-andeducation/Big-Picture/All-issues/Exercise-energy-and-movement/Imagegalleries/WTDV033068.htm

proteins we hit two or
more times in the yeast
two-hybrid screen.

Of the myofibrillar proteins, actin comprises approximately 20%.15, 16 Actin plays an important
contractile role in the sarcomere. In the yeast two-hybrid screen we hit two of the six actin
isoforms—skeletal muscle α actin 1 (ACTA1) and cardiac α actin 1 (ACTC1)—both of which
are implicated in pathogenic roles.17-21 Both skeletal and cardiac α actin are very similar, sharing
99% amino acid identity in the mature protein.22 Within the heart, the skeletal isoform is
expressed, although most of the actin (80%) is the cardiac isoform23. Acta1is cleaved and folded
into a 375 amino acid protein termed G actin. G actin polymerizes into F actin, which is the
filamentous form we observe in muscle.24 Functionally, actin forms the thin filament of the
sarcomere and interacts with the thick filament, composed of myosin.12 In concert with other
proteins, actin and myosin comprise a major part of the sliding filament mechanism, a theory by
which muscle contracts (see Figure 2.7).
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Myosin forms the thick
filament of the sarcomere
and makes up
approximately 50% of the
total myofibrillar
proteins.15, 16 Myosin
molecules are composed
of six proteins: two heavy
Figure 2.6 Transmission electron micrograph of cardiac muscle stained with uranyl

chains and two pairs of

acetate and lead citrate. Significant structures are labeled. Note the close
association between mitochondria and muscle cells. Image courtesy of Drs.
Toshitaka Yajima and Mark Murphy of the Veterans Medical Research
Foundation’s Microimaging Core Facility. http://www.vmrf.org/researchcenters/confocal

light chains—alkali or

/transmission-electron-microscope-images.html

essential, and regulatory

chains.12, 25, 26 Approximately 300 myosin molecules compose one myosin filament.14
Alongside actin, myosin fulfills an important contractile function in the sarcomere and is called
the “thick” filament. The sliding filament theory hypothesizes that myosin heads form cross
bridges that interact with actin filaments, shortening the sarcomere. Myosin cross-bridges (heads
bridging from the thick to the thin filaments) were first observed by Huxley in 1957, one study
upon which the sliding filament theory was established.27 In our yeast two-hybrid screen, we
observed multiple hits to different isoforms of myosin, including light chain 2 (MYL2), light
chain 3 (MYL3), and heavy chain 7 (MYH7). MYL2—whole name myosin, light chain 2,
regulatory, cardiac, slow—which was hit four times in the yeast two-hybrid screen, serves a
regulatory role in addition to its role as a contractile protein. Muscle contraction is regulated by
Ca2+ triggering the phosphorylation of the myosin regulatory light chain.28 Additionally, we hit
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MYL3 twice, another of the myosin light chains. This protein also fulfills a dual
regulatory/contractile role, however its function is less understood aside from providing
structural support to the myosin head.29 Researchers suggest possible pathogenic roles for
MYL3 in decreased myocyte function due to Myl3 cleavage by caspase-3.30 The heavy chain we
hit, MYH7—myosin, heavy chain 7, cardiac muscle, beta—helps compose the contractile unit of
the thick myosin filament
and is primarily expressed
in the normal human
ventricle.31 Like the
others, it has been
implicated in various
muscle defects; a mutation
in MYH7 was the first
hypertrophic
cardiomyopathy-causing
Figure 2.7. Model of muscle filament contraction. Myosin heads within the
sarcomere contract and move along actin filaments to pull Z-lines closer to each
other. By contraction of the sarcomere the muscle fibers shorten, thus shortening
the muscle as a whole. Image credit: http://en.wikipedia.org/-wiki/File:Sarcomere.svg.

gene to be discovered.32
In addition to slight

regulatory roles by the light chains of the myosin, other proteins in the sarcomere are involved in
regulating contraction. Our yeast two-hybrid screen also revealed interactions between HspB2
and the contractile regulators troponin I type 3 (cardiac) (TNNI3) and troponin T type 2 (cardiac)
(TNNT2). As a molecule, troponin is comprised of troponin-C, troponin-I, and troponin-T
subunits to make a three-subunit complex. The C subunit provides a binding site for calcium, the
T subunit provides an attachment site for the protein tropomyosin, and the I subunit attaches
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troponin to actin. To clarify, tropomyosin is a long filamentous protein that winds its way
around the actin filament. Together, the troponin protein complex holds the tropomyosin
filament onto the actin, blocking the active sites of the actin molecules.13, 14 Calcium (Ca2+)
binds to troponin C and facilitates removal of tropomyosin from the active site of actin, allowing
myosin heavy chain cross bridges to bind at one of its active sites. When ATP binds and is
cleaved at the other site on myosin, the energy is thought to be stored in the hinge region and
allows the myosin to pull itself along the actin filament. This, in turn, shortens the sarcomere
and the muscle as a whole.13, 14 With their significant roles in mind, and the constant contraction
and relaxation of heart muscle, it is not surprising that mutations of troponins I and T have been
linked to hypertrophic cardiomyopathy.33
In addition to the contractile and regulatory proteins mentioned above, our yeast two-hybrid
screen also suggests interactions between HspB2 and muscle proteins that serve structural roles.
Before discussing these proteins it is important to understand another element of the cell—the Zline. The Z-line is the dark line appearing at the border of each sarcomere (see Figure 2.6).
Composed mostly of the protein actinin, the Z-line anchors the actin filaments from the adjoining
sarcomeres.13 Many proteins interact at the Z-line, including several we pulled from the yeast
two-hybrid screen. These include titin (TTN), titin-cap (TCAP), desmin (DES), and myomesin 2
(MYOM2). Spanning from the Z-line to the M-line, the point halfway through the sarcomere,
titin serves the sarcomere by conferring elasticity to the muscle as well as helping to properly
situate the heavy filaments to the thin filaments.13, 14 TCAP, also called telethonin, binds two
parallel titin filaments to each other, and furthermore to the Z-line, in what is known as the
strongest observed protein-protein interaction.34, 35 Desmin, another protein found at the Z-line
and hit in our yeast two-hybrid screen, plays an integral role in the organization of the muscle
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fiber by joining adjacent sarcomere Z-lines to one another.14 Thus desmin enables the cell to
keep distinct organization of intermediate filaments as well as cross-bridging. Desmin also plays
a variety of alternate crucial roles in the muscle cell including interactions with the
mitochondria.36 Because of its varied roles in the cell, mutations to desmin are particularly
deleterious to the heart and cause what is termed desminopathy.37, 38
Not interacting at the Z-line, but nonetheless crucial to the function of the sarcomere, is the
protein myomesin 2 (MYOM2), a protein localized at the M-line.39 While its function is not
completely understood, myomesin 2 is found only in cardiac and fast skeletal muscle fibers and
is thought to help stabilize the myofibrillar thick filaments.12, 40 On a related note, four and a half
lim domains 2 (FHL2) is putatively thought to have a possible structural role in muscle due to its
localization to the Z-line, its expression solely in the heart, and a study showing an increased
hypertrophic response in mice lacking FHL2.41, 42
In addition to hits relating to the structural aspects of muscle, we also note important hits from
our yeast two-hybrid screen to several other muscle proteins. The cardiac isoform of myosin
binding protein (Mybpc3) has been implicated in contractile regulation by interaction with actin
or myosin filaments.43 Particularly interesting to our study is its relation to hypertrophic
cardiomyopathy—one study reports that greater than 40% of all hypertrophic cardiomyopathy
cases stem from MYBPC mutations.44 Of particular interest is the protein cardiomyopathy
associated 5 (CMYA5). CMYA5, also called myospryn in the literature, has been shown to
interact with several proteins including desmin and dysbindin. In addition, myospryn is in close
proximity to M-band titin, to intercalated discs in adult mouse heart, and is near lysosomes.45-47
Of course, as its name suggests, CMYA5 is thought to have an association to cardiomyopathy,
although Saparanta suggests that the name was given on purely hypothetical grounds.47 In
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support of its name, however, Nakagami et al have shown the relationship between a CMYA5
polymorphism and left ventricular wall thickness.48

Mitochondria

Most of our trillions of cells contain a copy of all of the genetic information which directs
multitudinous reactions and happenings throughout our body. In addition to our DNA,
eukaryotic cells contain various organelles that play an array of roles in the cell. Included among
these organelles are mitochondria, traditionally known as the cellular ATP powerhouses. Human
mitochondria, interestingly, possess unique DNA approximately 16,000 bp long and typically
contain between two and ten copies of their DNA, but can contain hundreds of copies in some
cases, such as in differentiating embryonic cells.49, 50 While the mitochondria have the
information (mitochondrian DNA, mtDNA) and machinery at hand to make proteins, most
(~99%) of the mitochondrial proteins are coded on nuclear DNA and are imported into the
mitochondria through several different protein import pathways.51-55 Our yeast two-hybrid
screen hit integral metabolic proteins with relation to the mitochondria. In an attempt to
categorize the proteins, I have grouped them into pathways in which they are involved. Of
particular interest are two proteins that we have hit nearly two hundred times in the screen, both
of which align to mitochondrion DNA with high similarity to the chromosomal genes encoding
NADH-ubiquinone oxidoreductase chain two-like and pterin-4-alpha-carbinolamine
dehydratase-2. Below I provide a basic overview of the processes involved and specify where
the various locations of protein hits from the yeast two-hybrid screen. I will discuss the
significance of the mitochondrial protein hits in Chapter 5, Discussion and Conclusions.
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Several of the proteins found to putatively interact with HSPB2 are key players in the glycolysis
pathway, namely hexokinase 1 (HK1), aldolase A (ALDOA), and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) (see Figure 2.8). Glycolysis, while not the most efficient method for
ATP production, provides an important source of energy for many cells in the body and forms
the precursors necessary for respiration. Its prevalence as an energy source is particularly of
interest in hypertrophied and failing hearts, as discussed more in Chapter 5.56 Starting with a
glucose molecule, the glycolytic pathway creates two molecules of pyruvate in two phases. In
the body, pyruvate is either converted to acetyl-CoA and used in the citric acid cycle or it
undergoes lactic acid fermentation. This later fermentative route is particularly appropriate for
tissues experiencing hypoxia. Hexokinase 1 is the first enzyme in the preparatory phase of the
glycolytic pathway. In this phase two molecules of ATP are expended to produce molecules that
lead to the payoff phase, the part of glycolysis in which four molecules of ATP and two
molecules of NADH are produced. Hexokinase 1 phosphorylates glucose to create glucose 6phosphate for use in further glycolysis reactions (see Figure 2.8). From this point, glucose 6phosphate is converted into fructose 6-phosphate and then fructose 1,6-bisphosphate by
phosphohexose isomerase and phosphofructokinase-1, respectively. From this point, aldolase A
cleaves fructose 1,6-bisphosphate into glyceraldehyde 3-phosphate and dihydroxyacetone
phosphate. Triose phosphate isomerase converts dihydroxyacetone phosphate into
glyceradehyde 3-phosphate. Both molecules of glyceraldehydes 3-phosphate are converted into
two molecules of 1,3-bisphosphoglycerate by the enzyme glyceraldehyde 3-phosphate
dehydrogenase. This reaction is the first energy-yielding reaction of glycolysis because it
produces two molecules of NADH. Also involved in glycolysis is enolase 3, beta, muscle
(ENO3). It is muscle specific and plays a metabolic role by catalyzing the conversion of 239

phosphoglycerate to 2-phosphoenolpyruvate, a pivotal step in glycolysis.50, 57 We will discuss
the significance of these putative interactions with HspB2 in Chapter 5.
In addition to the conversion of carbohydrates into usable forms of cellular energy, lipids are also
an important starting point in the production of cellular energy. Fats undergo hydrolysis into
fatty acids and are then oxidized by α-, ω-, or β-oxidation. Following oxidation, the fatty acids
move from the cytosol to the mitochondria. The majority of fatty acids undergo β-oxidation, and

Figure 2.8. The pentose phosphate pathway, glycolysis, and citric acid (i.e. TCA) cycle. For details as to which enzymes
HspB2 has been found to putatively interact, please see the text .

40

this pathway is of particular interest because we hit a protein in the pathway in the yeast twohybrid experiment. This protein, electron-transfer flavoprotein, alpha polypeptide (ETFA),
accepts electrons from a variety of dehydrogenases, including acyl-CoA dehydrogenase, an
enzyme catalyzing the first step of β-oxidation.58-60 The last stage of β-oxidation of fats occurs
with the help of acetyl-CoA acyltrasferase (ACAA2), another protein we hit twice in the yeast
two hybrid screen.60 Acyl-CoA molecules are further converted into acetyl-CoA for use in the
citric acid cycle.
The citric acid cycle (also known as the TCA or Kreb’s cycle), is the pathway by which energy is
produced via the conversion of acetyl CoA to carbon dioxide and water.61 The energy output of
the citric acid cycle varies greatly with the length of the carbon chain, but provides a
substantially greater contribution than glycolysis to the production of ATP.60 Note from above
that acetyl CoA is not solely derived from carbohydrates, but can be derived from other sources
such as lipids and proteins. Occurring in the mitochondrial matrix, the citric acid cycle is a
series of conversions from one molecule to another. One step in the citric acid cycle converts
one molecule of succinate to fumarate via catalysis by succinate dehydrogenase. This is of
interest to us because we detected putative interaction between succinate dehydrogenase
complex, subunit A, flavoprotein (Fp) (SDHA), and HspB2 in our yeast two-hybrid screen. As
discussed below, SDHA also plays an important role in the electron transport chain. Oxidative
phosphorylation, put simply, is the process of transferring electrons from energy molecules such
as NADH and FADH2 through a chain in which oxygen is the final electron acceptor.61
Electrons pass through a series of electron carriers and complexes in the inner mitochondrial
membrane, the carriers and complexes forming a “chain” of events, thus giving this process the
name “electron transport chain” (see Figure 2.9).61 Complex I is known as NADH
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dehydrogenase.62 Its function is to transfer electrons from NADH to the carrier coenzyme Q.
We have hit several parts of this complex, although each was hit only one time (see Table 2.2).
Complex II is the succinate-Q reductase complex. This complex donates electrons from FADH2
to coenzyme Q. One of the three enzymes which composes complex II is succinate
dehydrogenase (SDHA). Next in the electron transport chain, coenzyme Q transfers electrons
through the inner mitochondrial membrane to complex III, known as cytochrome c reductase.
Electrons are then donated to cytochrome c, which transfers electrons from complex III to
complex IV, cytochrome oxidase. We hit different subunits of cytochrome c oxidase,
(COX6C,and COX 7B), Complex
IV transfers electrons from
cytochrome c to O2. Throughout
this process, protons have been
moved through the complexes I,
III, and IV into the intermembrane
space, creating a proton gradient of
1:10; 10 intermembrane space
protons for every one matrix
proton.62 The last complex in the
Figure 2.9. Summary of electron transport chain. Electrons are carried
along a chain of protein complexes within the inner mitochondrial
membrane. The yeast two-hybrid screen has hit several proteins
imperative in this process. For details, see text.. Image credit:
http://en.wikipedia.org/ wiki/File :Mitochondrial_electron_transport_chain%E2-%80%94Etc4.svg

chain, ATP synthase, allows
protons to flow back into the
matrix and uses the energy from

their return to create ATP.62 Part of this complex, the ATP synthase, H+ transporting,
mitochondrial F1 complex, alpha subunit 1, cardiac muscle (ATP5A1), was hit three times in the
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yeast two-hybrid screen. Since the electron transport chain generates large amounts of energy
for the cell, dysfunction of any of the involved proteins is detrimental to the energy levels of the
cell, and many pathological conditions exist. Chapter 5 discusses the possible pathologic
implications the involvement of HspB2 with the various proteins that help to produce energy for
the cell and links our results to previously discovered defects in ATP production in HspB2deficient mice. Adenylate kinase 4 (AK4) was also hit in the yeast two-hybrid screen. It has
been shown to localize in the mitochondrial matrix.63 AK4 has extensive ability to
phosphorylate and has been shown to retain its enzymatic function once imported into the
mitochondria.64
Several other mitochondrial proteins of interest have been hit that do not correspond to energy
production in the cell. Methylmalonic aciduria (cobalamin deficiency) cblD type with
homocystinuria (Mmadhc), has been hit twice in the screen. This protein is involved in the
metabolism of vitamin B12, a molecule essential for human development and survival.65 Its
name stems from the fact that mutations in the gene cause either methylmalonic aciduria,
homocystinuria, or both.66 Another protein, mitochondria translation initiation factor 3 (MTIF3)
is involved in initiation complex formation on mitochondrial ribosomes.67 We hit MTIF3 twice
in the yeast two-hybrid screen. Of particular interest are two proteins we have hit 186 times.
They align to two categories, each with homology to mitochondrion DNA: pterin-4-alphacarbinolamine dehydratase-2 (PCBD2) as well as NADH ubiquinone oxidoreductase chain 2like. PCBD2 has been shown to have similar enzymatic and coactivator activities to PCBD1.
PCBD1 serves as a coactivator of transcription as well as pterin-4-alpha-carbinolamine
dehydratase activity, a process playing a role in amino acid hydroxylases and nitric oxide
synthase.68-70 Interestingly, a role for sHSPs in the regulation of nitric oxide production, a
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known regulator of mitochondrial Ca2+ uptake, has already been hypothesized.71, 72 By
homology, NADH ubiquinone oxidoreductase chain 2-like probably functions as a subunit of
complex I in the respiratory electron transport chain.73 As discussed in chapter 5, these
intriguing findings could suggest an intimate relationship between HSPB2 and several
potentially uncharacterized proteins. Overall, more hits from our yeast two-hybrid are of
mitochondrial association than any other category.

Electrolyte-Related

Maintenance of electrolyte levels in the cell is crucial for maintaining cellular function. Several
of the electrolyte-related proteins were hit in our yeast two-hybrid screen. We hit CLIC6,
chloride intracellular channel 6, twice in the screen. The CLIC family of proteins is thought to
code for intracellular chloride channels, however a study in 2003 failed to find any chloride
channel activity by voltage clamp studies.74 Thus, the function of this protein is unknown. We
also hit several ATPase genes that code for channel proteins (see Table 2.2). The most
interesting channel proteins we hit in the yeast two-hybrid screen are voltage-dependent anion
channels 1 and 2. The VDAC proteins are the most abundant proteins in the outer mitochondrial
membrane and are of particular interest because of their functions relate to apoptosis.75 VDAC1
typically is pro-apoptotic, while VDAC2 has been shown to prevent apoptosis.75-80 The
significance of these proteins is discussed in further detail in chapter 5.
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Kinases

Two protein kinases have been hit in the yeast two-hybrid screen. Adrenergic beta receptor
kinase I, ADRBK1—also called GRK2 in the literature—is thought to play an important role
with relation to heart failure. Studies show that it is a regulator of the heart’s inotropic response
and that it is upregulated in heart failure with nonfailing myocardium.81-84 Additionally, we hit
mitogen-activated protein kinase-activated protein kinase 3 (MAPKAPK3). Interestingly,
MAPKAPK3 was shown to be activated in response to cellular stress, a particular finding that
perhaps has relation to HSPB2. Researchers also showed that this kinase performs in vivo
phosphorylation of HSP27, another of the sHSPs.85 The significance of potential interactions
with kinases is discussed more in chapter 5.

Redox

The yeast two-hybrid screen has yielded putative interactions between HspB2 and two redox
proteins, namely, glutathione peroxidase 3 (GPX3), and thioredoxin interacting protein
(TXNIP,). Many diseases, including rheumatoid arthritis, reperfusion injury, cardiovascular
disease, immune injury, and cancer, are associated with the production and presence of free
radical species of oxygen.86, 87 Of particular interest to us is the importance of radical oxygen
species production by the heart, especially during times of ischemia and reperfusion.87
Glutathione peroxidase 3 protects the heart by its antioxidant ability to scavenge hydrogen
peroxide and other hyperoxides produced in the cell.88, 89 TXNIP interacts with and inhibits
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thioredoxin antioxidant function and is suppressed by mechanical strain. Overexpression of
TXNIP results in greater levels of reactive oxygen species in the cell.90

Small Heat Shock Protein

As discussed in detail in chapter 1, sHSPs confer stress resistance to the cell. In the yeast twohybrid screen we hit two sHSPs: αβ-crystallin (CRYAB, 17 hits). As discussed previously,
CRYAB is highly expressed in the lens of the eye as well as in the heart where it serves as a
protein chaperone.91-93 Mutations in CRYAB have been shown to cause cardiomyopathy,
however the mechanisms of action are currently unknown. Further significance of the
relationship between HspB2 is discussed in Chapters 4 and 5.

Other

While there are several other proteins we hit in the yeast two-hybrid screen, they do not all fit
into the categories discussed above. For a brief list and description see Table 2.2.
The primarily mitochondrial and muscle hits from the yeast two-hybrid screen for interactions
with HspB2 confirm a role for HspB2 in muscle ATP production and identify key potential
substrates. As mentioned previously, hits from the yeast two-hybrid screen do not necessarily
denote protein-protein interactions, however they do suggest the possibility of such. Further
tests are necessary to come to the conclusion that the aforementioned proteins interact with
HspB2, including the HspB2 dependency test (see chapter 3) and coimmunopurification in
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mammalian cells (see chapter 4).

Figure 2.10. Pie chart of the yeast two-hybrid protein hits. Results were tabulated using the information from Table 2.2. Note
that several of the proteins were batched together and treated as one protein: i.e. NDUF proteins and ATPases.
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Table 3.2. (below) Table of proteins hit more than once from the yeast two-hybrid screen. These 55 proteins are
of particular interest because of their involvement in various cellular processes. Brief summary descriptions come
largely from in-text citations, however in cases wherein the protein was not discussed in-text short descriptions are
summaries of entried found at genecards.org/Wikipedia.org/OMIM for the respective proteins.

Muscle Proteins
Gene Abbrev.

Full Gene Name

Hits

Summary

ACTA1

Actin, alpha 1, skeletal muscle

3

Thin filament;
contractile function

ACTC1

Actin alpha, cardiac muscle 1

16

Thin filament;
contractile function

2

Possible muscle
structural
maintenance

2

Structural muscle
protein, found at Zline

CMYA5

DES

Cardiomyopathy associated 5

Desmin

FHL2

Four and a half LIM domains 2

2

Structural muscle
protein, found at Zline

MY0M2

Myomesin (M-protein) 2

2

Putative role in
muscle stabilization

6

Contractile,
regulation/myosin
filaments

MYBPC3

Myosin binding protein C, cardiac

MYH7

Myosin heavy chain 7 cardiac muscle, beta

5

Composes
contractile heavy
chain

MYL2

Myosin light chain 2 regulatory cardiac slow

4

Regulatory and
contractile roles

MYL3

Myosin, light chain 3, alkali; ventricular, skeletal, slow

2

Regulatory and
contractile roles

TCAP

Titin-cap (telethonin)

2

Structural muscle
roles

TNNI3

Troponin I type 3 (cardiac)

2

Attaches troponin
to actin

TNNT2

Troponin T type 2 (cardiac)

2

Attaches troponin
to tropomyosin
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TTN

Titin

2

Confers elasticity
to muscle;
organization

Mitochondrial Proteins
Gene Abbrev.

Full Gene Name

Hits

Summary

ACAA2

Acetyl-CoA acyltransferase 2

2

Involved in βoxidation of fatty
acids

ALDOA

Aldolase A, fructose-bisphosphate

6

Involved in
glycolysis

ATP5A1

ATP synthase, H+ transporting, mitochondrial F1
complex, alpha subunit 1, cardiac muscle

3

Involvement in the
electron transport
chain

8

Involvement in the
electron transport
chain

2

Involvement in the
electron transport
chain

COX6C

COX7B

Cytochrome c oxidase subunit Vlc

Cytochrome c oxidase subunit 7B

ENO3

Enolase 3 (beta, muscle)

3

Muscle protein
with involvement in
glycolysis

ETFA

Electron-transfer-flavoprotein, alpha polypeptide

4

Electron acceptor in
β-oxidation

GAPDH

Glyceraldehyde-3-phosphate dehydrogenase

6

Involved in
glycolysis

HK1

Hexokinase 1

2

Involved in
glycolysis

MMADHC

Methylmalonic aciduria (cobalamin deficiency) cblD
type, with homocystinuria

2

Vitamin B12
metabolism

MTIF3

Mitochondrial translation intitiation factor 3

2

Initiation complex
formation

102

Putative subunit of
complex I in
electron transport
chain

-NDUFA3
49

Mitochondrion with NADH-ubiquinone oxidoreductase
chain 2-like
NADH dehydrogenase (ubiquinone) 1 alpha

1

Subunit of complex
I in electron

subcomplex, 3, 9kDa

NDUFA6

NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 6, 14kDa

NDUFAF1

NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, assembly factor 1

PCBD1-like

SDHA

Mitochondrion with pterin-4-alpha-carbinolamine
dehydratase-2

Succinate dehydrogenase complex, subunit A,
flavoprotein (Fp)

transport chain

1

Subunit of complex
I in electron
transport chain

1

Subunit of complex
I in electron
transport chain

84

Coactivator of
transcription and
other enzymatic
function

5

Involvement in
citric acid cycle and
electron transport
chain

Electrolyte-related Proteins
Gene Abbrev.

ATP1A1

ATP1B1

ATP1B3

Full Gene Name

ATPase, Na+/K+ transporting, alpha 1 polypeptide

ATPase, Na+/K+ transporting, beta 1 polypeptide

ATPase, Na+/K+ transporting, beta 3 polypeptide

Hits

Summary

1

Integral membrane
protein Na+/K+
exchanger

1

Integral membrane
protein Na+/K+
exchanger

1

Exact function
unknown; noncatalytic part of the
enzyme

ATP2B4

ATPase, Ca++ transporting, plasma membrane 4

1

Assists in removal
of calcium ions
from the cells

CLIC6

Chloride intracellular channel 6

2

May form chloride
ion channels
Forms channel
through outer
mitochondrial
membrane; proapoptotic

VDAC1

Voltage-dependent anion channel 1

4

VDAC2

Voltage-dependent anion channel 2

2

50

Forms channel
through outer

mitochondrial
membrane;
antiapoptotic
Redox-related Proteins
Gene Abbrev.

Full Gene Name

GPX3

Glutathione peroxidase 3

TXNIP

Hits

Summary

2

Neutralization of
hydrogen peroxide

2

Inhibitor of
thioredoxin
antioxidant
function

Hits

Summary

Thioredoxin interacting protein

Kinase Proteins
Gene Abbrev.

Full Gene Name

ADRBK1

Adrenergic beta receptor kinase I

MAPKAPK3

Mitogen-activated protein kinase-activated protein
kinase

1

Regulates inotropic
response of heart

1

Activated in
response to stress

Small Heat Shock Proteins (sHSPs)
Gene Abbrev.

CRYAB

Full Gene Name

Hits

Summary

Crystallin, alpha B

17

Highly expressed
in heart and skeletal
muscle; R120G
mutation confers
cardiomyopathy

Full Gene Name

Hits

Summary

3

Serum protein
associated with
MHC heavy chain

3

RNA-binding
protein

2

Putative role in
apoptosis

7

Elongation factor
subunit

Other Proteins
Gene Abbrev.

B2M

Beta-2-microglobulin

DAZAP2

DAZ associated protein 2

DBNDD2

Dysbindin (dystrobrevin binding protein 1) domain
containing 2

EEF1A1
51

Eukaryotic translation elongation factor 1 alpha

GPR146

G protein-coupled receptor 146

2

Involvement in
membranes/Gprotein receptors

GUK1

Guanylate kinase 1

3

Guanine
metabolism

LGALS1

Lectin, galactoside-binding, soluble, 1

4

Possible
apoptosis/cell
proliferation/cell
differentiation
protein

MALAT1

Metastasis associated lung adenocarcinoma transcript 1
(non-protein coding)

2

Possible links to
lung cancer

4

Neuroprotective
and antiapoptotic
function

MTRNR2L2

MT-RNR2-like 2

NPPA

Atrial natriuretic peptide A

5

Helps in the
regulation of
natriuresis/diuresis/
vasodilation

PSAP

Prosaposin

5

Precursor for
cleavage products

RPL11

Ribosomal protein L11 transcription variant 2 mRNA

3

Subunit of 60S
ribosomal subunit

RPL36A

Ribosomal protein L36A

6

Subunit of 60S
ribosomal subunit

2

Membrane protein
associated with
rough ER

RPN2

Ribophorin II

SEC62

SEC62 homolog (S. cerevisiae)

3

Preprotein
translocation (by
similarity)

SNRPG

Small nuclear ribonucleoprotein polypeptide

2

Possible histone 3’end processing
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CHAPTER THREE: Aim Two: Verify putative HspB2 binding partners in yeast by the
HspB2 dependency test.

Introduction
As mentioned previously, the yeast two-hybrid screen generated a large list of possible proteinprotein interactions between HspB2 and the library of human heart proteins. While these
findings are valuable, further verification in yeast, and later in mammalian cells, is required for
results to be credible. The HspB2 dependency test allows us to determine whether an interaction
garnered from Aim One is a true or false interaction in yeast. This additional means of
verification show us if expression of the reporter genes is dependent on the presence of the
protein and its interaction with HspB2. Due to the labor-intensive nature of these tests, we
perform them only with proteins we have recovered two or more times from the screen. As
discussed in chapter two, the yeast two-hybrid system can serve two purposes. It can be used as
a method of screening for interactions with a cDNA library as well as its use to test putative
protein-protein interactions.1 The HspB2 dependency test is an example of the latter.
HspB2 dependency tests required us to first purify each prey plasmid. Following purification the
plasmids are transformed into yeast, the yeast are allowed to grow under selection for both
plasmids, and then are streaked to media that will confirm an interaction as explained below..
We purify the plasmids from yeast by first selecting from the 91-grid plate the appropriate yeast
harboring the protein that putatively interacts with HspB2. From the 91-grid plate the yeast
should, in theory, contain two types of plasmids—the bait and the prey plasmids. Recall from
Chapter Two that the bait plasmid contains the gene for HspB2 fused to the GAL4
transcriptional activator DNA-binding domain. On this same plasmid is TRP1, a tryptophan
biosynthesis gene. The prey plasmid contains cDNA made from a library of mRNA collected
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from three normal male hearts. The library gene is fused to the GAL4 transcriptional activator
activation domain. Recall also that the prey plasmid contains a gene for leucine biosynthesis
(LEU2). In order to select for only the prey plasmid and ensure that we have plenty of yeast for
purification, we grew yeast for two to three days in synthetic glucose media lacking leucine (SDLeu media). When grown in SD-Leu, media that lacks leucine but includes tryptophan, the yeast
will jettison the bait plasmid because it is energetically expensive to maintain a plasmid that is
not necessary for its survival. . Next, we centrifuged the yeast, aspirated the media, and treated
the yeast with lyticase and 10% sodium dodecyl sulfate (SDS) (see Protocols in Appendix). The
lyticase procedure is necessary to lyse the yeast due to the presence of the robust yeast cell wall.
Next, lysed yeast go through the Sigma-Aldrich GenElute™ Plasmid Miniprep Kit. Since yeast
do not typically maintain a high copy number of its plasmids per cell like in E. coli, after the
purification procedure we have recovered a very low concentration of plasmid—hardly
detectable by spectrophotometric analysis. In order to amplify the concentration of plasmid
available we transform a portion from the yeast plasmid prep into the DH5α strain of Escherichia
coli and grow on LB+amp (LB is lysogeny broth, amp is the antibiotic ampicillin) plates since
the prey plasmid contains an Ampr marker. Single E. coli colonies growing on the LB+amp
plates are chosen and are grown in LB-amp liquid overnight. We next perform plasmid preps on
the E. coli using the same kit used previously. We sequence library genes contained on the
plasmids in order to verify their identity. Following sequencing, the plasmid is entered into the
Grose Lab plasmid database by giving it a number that is unassociated with its identity (i.e. pJG
745). Renaming the plasmids allows us to perform the HspB2 dependency tests blindly, helping
to eliminate potential bias.
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We transform each prey plasmid into
two different yeast strains: a yeast
strain containing the bait plasmid
encoding HspB2 (pJG593A) and a
strain containing an empty vector
plasmid that does not express HspB2
but that does encode the tryptophan
biosynthesis gene (pJG485) (see
Figure 3.1). Both strains of yeast are
created from the same Matchmaker™
Gold (Y2HGold) strain of yeast used
in the yeast two-hybrid screen in Aim
Figure 3.1. HspB2 dependency test. Plasmids are transformed into
yeast as shown above. A plasmid containing a gene from the library)
(Protein X) and the HSPB2 plasmid are co-transformed into the
Y2HGold yeast strain (Clontech). In addition, protein X plasmid is
transformed along with an empty vector into the same strain in a
separate transformation. Growth on selective media will verify
expression of reporter genes due to protein X/HspB2 interaction. In
order for dependency to be established, yeast possessing HSPB2
plasmid must grow on selective media while the Protein X and
Empty Vector plasmid-containing yeast will not grow. Thus the cell
is “dependent” upon the presence of HspB2 in order for expression
of reporter genes.

One. After the yeast is transformed
with the bait plasmid we grow it on
SD-Leu-Trp plates to select for yeast
in which the transformation has
occurred. Yeast that grow on this
media contain each of the two

plasmids, however growth at this stage does not denote a protein-protein interaction. In order to
determine whether the proteins interact with each other and thereby initiate transcription of
various reporter genes, we streak a colony containing the library (Protein X) and HspB2 plasmid
onto synthetic glucose plates lacking leucine, tryptophan, histidine, and adenine (SD-Leu-TrpHis-Ade plates) alongside a colony containing both the library and the empty vector plasmids.
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Colonies that grow regardless of whether the library plasmid is transformed along with the baitor empty vector are deemed false-positives. This is because they activate transcription regardless
of the presence of HspB2. Colonies that do not grow in either situation are deemed true
negatives and most likely arise from chromosomal mutations or other artifacts. Colonies that
grow in the presence of the HSPB2 plasmid but do not grow in the presence of the empty vector
plasmid are deemed HspB2 dependent because growth is dependent on the expression of HspB2
(see Figure 3.2). We perform each HspB2 dependency test in duplicate from two independently
isolated library plasmids as determined in Aim One. If growth on selective media is decidedly
dependent on HspB2 with one copy of a gene and we find the other copy of the same gene differ
in its dependency status, the transformations and dependency tests are repeated and the results
compared again.
Yeast provide a simple eukaryotic environment in which we can test protein-protein interactions.
We use the yeast two-hybrid system to detect protein-protein interactions as well as to verify
them in yeast. Although these results do not always translate into interactions in mammalian
cells, a previous study reports that approximately 80% of yeast two-hybrid results are then
verifiable in mammalian cells.2. Verification first by yeast two-hybrid and then by HspB2
dependency tests provide credible data ready for further testing in mammalian cells, as follows in
Aim Three.
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Figure 3.2. (see below) HspB2 dependency test plate containing yeast streaked onto selective media (SD-Leu-TrpHis-Ade). Colonies that have grown on this selective plate are determined to be dependent upon the presence of
HspB2 in the cell since only yeast containing both library plasmid and HspB2 grow. This plate confirms that
expression of yeast two-hybrid reporter genes is dependent on an interaction between Acta1 and Atp5a1 with
HspB2.
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Results
Results for the HSPB2 dependency tests can be found in Table 3.1. For a short description of the
various functions, please see the in-text protein descriptions in Chapter 2 or refer to Table 2.2.
Proteins confirmed to be HspB2 Dependent

ACAA2
ACAA2
ACTA1
ACTA1
ATP5A1
ATP5SL
CMYA5
CMYA5
COX6C
COX7B
CRYAB

CRYAB
DES
EEF1A1
ENO3
ENO3
GAPDH
GAPDH
GPR146
GPR146
GPX3
GPX3

GUK1
Mito/pterin
Mito/pterin
Mito/NADH
Mito/NADH
MTIF3
MTRNR2L2
MYBPC3
MYL3
MYL3
PARVA

RPL36A
RPN2
SDHA
SEC62
SNRPG
TNNI3
TNNI3
TNNI3
TXNIP

Table 3.1. Proteins confirmed to be HspB2 dependent.
Each gene is tested in duplicate from two independent
plasmids isolated from the screen. Note that some have
been done more than twice.
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CHAPTER FOUR: Aim Three: Verify putative HspB2 binding partners in mammalian
cells (HEK 293).
Introduction

HSPB2 dependency tests were conducted after identifying putative interactions between HSPB2
and a library of human heart proteins in the yeast two-hybrid screen (Chapter Three). Following
HSPB2 dependency testing we moved on to verification in mammalian cells in order to gain
more credible results. Many methods exist for the detection of protein-protein interactions,
however, one of the most trusted methods for verification is coimmunopurification.1 Since coimmunoprecipitation is laborious, generally only a subset of yeast two-hybrid hits are tested. We
began our verification by testing HspB2 with itself (a known interaction), and HspB2 with
CryAB (a hit from our screen).
Co-immunopurification has been used widely in the literature to identify protein-protein
interactions. In essence, the experiment is comprised of purifying a target protein from cell
lysate and testing to see if another protein copurified through association with the target protein.
After purification the samples are run on Western blot, which consists of running a protein gel,
blotting to a nitrocellulose membrane, and imaging with antibodies to detect proteins of interest.
Our co-immunoprecipittion experiment to verify the yeast two-hybrid interactions was set up as
follows. An empty pCMV-myc as well as pCMV-HA vector set was purchased from Clontech,
which would allow expression of our fusion proteins of interest from the CMV promoter.
Plasmids (pCMV-myc) containing HspB2-myc were provided to us by our collaborators, the
Ivor Benjamin lab. Plasmids containing CryAB-HA were created by subcloning CRYAB
obtained from one of the “prey” plasmid isolated in our screen through the restriction enzymes
SfiI/XhoI, which allows direct, in-frame cloning into pCMV-myc. The resulting plasmids were
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then transfected in HEK 293 cells. Plate A contained the following transfections: pJG550
(HspB2-myc) with pJG552 (HspB2-HA), with pJG904 (CryAB-HA), and with the empty HA
vector. Transfections were performed in duplicate and two wells from the 6-well plate were
combined in order to ensure that adequate protein was available for CoIP. Plate B was
transfected in the same manner, but with pJG554, an empty pCMV-myc clone, instead of
pJG550. This was used as a negative control.
We chose to conduct our experiment in HEK 293 cells because of their ease of culturing and
transfecting. Our cells were graciously given to us by the Laura Bridgewater lab at Brigham
Young University, to whom we owe thanks. We cultured cells in Gibco DMEM high glucose
(Life Technologies Cat. No. 11960-051) supplemented with 4mM sodium pyruvate, 4mM Lglutamine, and 10% fetal bovine serum (FBS). Cells were cultured in 75 cm2 Greiner filtercapped flasks. When split, cells were released from the flask surface using .05% trypsin-EDTA
and light bumping of the flask. Transfection was performed with Lipofectamine LTX per the
instructions specific for transfecting HEK 293 cells.2. The media was changed approximately
five hours after transfection was performed to reduce toxic effects from Lipofectamine. Cells
were allowed to grow for approximately 48 hours after transfection and were harvested with 0.5
mL lysis solution (0.5% NP-40, 20mM Tris-HCl [pH 7.8], 180mM NaCl, 1mM EDTA, and
complete protease inhibitor cocktail). We placed the cells on ice for approximately 20 minutes
with gentile shaking and collected them in 1.5mL tubes after which they were put in a rotator for
10 minutes. Tubes were then centrifuged at 15,000rpm for 15 minutes to remove debris. The
supernate was removed and placed into a newly-labeled tube that had chilled on ice. Note that it
is critical to keep everything as cold as possible throughout the process so as to inhibit potential
proteases. The contents of the tubes at this point contained what is called the crude lysate. 50μL
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of crude lysate is prepared for gel electrophoresis by the addition of 12μL of 5x SDS loading
buffer followed by boiling for 5 minutes. These samples are then placed in the freezer. 20μL of
washed and buffer equilibrated anti-myc antibody beads were added to the remaining .45mL that
is then incubated at 4oC for approximately four hours. The washing and equilibration of
antibody beads is a crucial step and must be performed well in order to achieve good binding of
protein to the beads (see the appendix for a precise protocol). After beads have been incubated
with the cell lysate, the beads are pelleted then washed three times with 1mL cold NP-40 lysis
buffer. After the third wash, the lysis buffer is removed and 30μL of 4x SDS loading buffer is
added. The tubes are then boiled for 5 minutes, spun down for 30 seconds, and kept on ice or in
the refrigerator/freezer for the protein gel and Western blot. Results for our CoIP experiment
are detailed below.
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Results

The co-immunoprecipitation experiment successfully verified the known interaction between
HspB2 and itself as well as a novel interaction between HspB2 and CryAB (Figure 4.1). The
plasmids pJG550 (HspB2-Myc) and pJG552 (HspB2-HA) were co-transfected as a positive
control because sHSPs have been shown to interact with themselves to form dimers.3 The
second set of transfections was pJG550 (HspB2-Myc) with pJG904 (CryAB-HA), this was our
interaction in question. Since CryAB was hit multiple times in the yeast two-hybrid screen and it
was shown to interact in the HSPB2 dependency test (Chapter Two), this coimmunoprecipitation was the final step in verification.
It is necessary in co-immunoprecipitation experiments to have adequate controls to make
sure you have detected a true interaction between proteins. The third transfection was with
pJG550 (HspB2-Myc) and the empty HA vector. This was our negative control and allowed us
to make sure that it wasn’t the HA that bound the myc beads or the HspB2-Myc protein. A
duplicate plate was transfected with pJG554 (empty pCMV-myc) replacing pJG550 (HspB2Myc) as the other necessary negative control, although it is unlikely that CryAB would bind to
the myc-sepharose beads.

This plate included pJG551 (empty pCMV-myc) transformed with

pJG552 (HspB2-HA), pJG904 (CryAB-HA) and empty pCMV-HA.
Results of the co-immunoprecipitation are shown in Figure 4. The first image is a 20
minute exposure using anti-HA beads to detect protein. Since we can see bands corresponding to
the sizes of HspB2-HA (lane 1), and CryAB-HA (lane2) from the transfections done with
HspB2-Myc, but not empty pCMV-myc this tells us that 1) HspB2 dimerizes, 2) HspB2 and
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CryAB bind one another, and 3) none of the proteins bound to Myc or HA alone. The
significance of this novel HspB2-CryAB interaction will be discussed in Chapter 5.

Figure 4.1. Western blot of coimmunopurification with anti-Myc beads. The left panel is an anti-HA blot of the
anti-Myc purification. The right panel denotes an anti-Myc blot of the anti-Myc purification. This figure identifies
a novel interaction between HspB2 and CryAB. See text for additional information.
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CHAPTER FIVE: Discussion and Conclusions

Discussion and Conclusions
Characterizing protein-protein interactions within the cell is a powerful method for
understanding protein function. Studies to date had not sought the identification of interacting
pairs on a library-wide scale for any of the small heat shock family, but rather with proteins
already suspected to bind to HspB2. In fact, only three proteins had previously been shown to
interact with HspB2, HspB3 and Hsp20.1, 2 The yeast two-hybrid screen afforded us a look into
the normal binding partners of HspB2, allowing a chance to characterize the protein at a broad
level.
Although the yeast two-hybrid screen is quite sensitive and false positive rate is relatively low,
HspB2 dependency tests allowed us to verify suspected interactions uncovered by yeast twohybrid. We had a verification rate of approximately 80% in yeast. In the case of one of the
important proteins in the heart (CryAB), additional verification was performed by coimmunoprecipitation. These additional forms of verification produced a set of results with
varying surety: those only confirmed through yeast two-hybrid are slightly less sure of a true
interaction than those undergoing the HspB2 dependency tests. These, even, are less sure that
the protein interaction confirmed by co-immunopurification.
In this section of discussion and conclusions I will recall important findings from the project,
ending with the interaction of which we are most certain. As I discuss the results it will be
apparent that the data gathered is significant in that it characterizes the role of HspB2 as a protein
involved in both muscle and mitochondrial function. HspB2 plays an important role in helping
the cardiac myocytes maintain structural, contractile, and regulatory muscle function while also
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maintain the energy resources and process of catabolism necessary for running such an energyintensive system as the heart. Finally, possible sources of error and suggested roads for future
experiments are addressed.
Fortunately, the yeast two-hybrid system purchased and used in these experiments is one of the
most advanced and sensitive systems available for research. Especially of interest is the Mate
and Plate library that was available for purchase which afforded us a method of detecting
interactions with a library of human heart proteins. Proteins which were pulled out of the screen
represent a putative group of HspB2:protein interactions. Further steps of verification allow a
more complete view of the role of HspB2 in the heart. Although results conducted thus far with
yeast two-hybrid alone offer important insights into HspB2 function within the heart, further
verification in mammalian cells is vital.
Important in characterizing HspB2 in the heart is, as mentioned above, its prevalence in
maintenance of muscle and mitochondrial function. We will discuss proteins which were found
to interact with HspB2 through yeast two-hybrid alone, followed by interactions verified in the
HspB2 dependency tests, and finally the important finding verified by coimmunopurification.
An effort will be made to relate protein hits to potential pathological relationships, especially
cardiomyopathy. In this manner we will move through the results, finishing with the proteinprotein interaction of which we are most sure occurs within the cell.
A large quantity of proteins have been found to interact with HspB2, although many of them
have only been pulled out only a single time from the screen, suggesting possible false positives.
The yeast two-hybrid uncovered proteins involved in structural, contractile, and regulatory roles
within the muscle cell. This finding helps to characterize HspB2 as being heavily involved in the
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maintenance of muscle. While the system of detection is not particularly “stressed” in terms of
cellular stress inducing expression of sHSPs, it is likely that during times of stress the
interactions observed in yeast two-hybrid would only become more pronounced rather than being
different from the observed interactions.
In light of the interactions observed in Chapter Two under the “Muscle” heading, it is not
surprising that many of the proteins found to putatively interact with HspB2 are also implicated
in disease, specifically in cardiomyopathy. This fact gives significance to the study because
cardiomyopathy, while not a widespread problem, is one of concern and great importance in
public heath circles.3 Behind coronary artery disease and hypertension, for instance, dilated
cardiomyopathy is the United States’ leading cause of heart failure and hypertrophic
cardiomyopathy—the leading cause of sudden death in athletes.4, 5 Thus, an increased
understanding of potential players in the disease may lead to better treatments.
Of the muscle proteins hit in our yeast two-hybrid screen, many have relation to cardiomyopathy.
Up to three-quarters of all cases of hypertrophic cardiomyopathy originate from mutations in two
genes, MYH7 and MYBPC3, two proteins which were hit multiple times in the screen. Recall
that these myosin proteins comprise the thick filaments of muscle and are necessary for muscle
contraction. Also involved in cardiomyopathy are mutations in actin, another of the proteins we
hit in the yeast two-hybrid screen.6, 7 Actin, myosin, desmin and many others proteins discussed
in chapter 3 are required for maintenance of proper muscle structure and contraction. Many of
these have been implicated in cardiomyopathy when mutated, however, other sources of
cardiomyopathy have been observed.
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Crucial to the function of muscle is the ability for mitochondria to produce ATP and fuel the
contraction of myosin heads. ATP is produced by the catabolism of various sources of energy:
carbohydrates, fats, and even proteins. Converting foods to energy is a network of enzymes
catalyzing a variety of reactions, many of which occur in the mitochondria and which have been
hit in the yeast two-hybrid screen. HspB2 has been shown to localize to the outer membrane of
mitochondria.8 We hit VDAC1 and VDAC2, genes that encode proteins that are situated within
the outer mitochondrial membrane, suggesting that perhaps this is one location to which HspB2
localizes. Because we hit many proteins found to localize to the mitochondrial matrix and inner
mitochondrial membrane this study suggests that HspB2 also functions inside the mitochondria
or helps fold proteins entering the mitochondria. Indeed, nearly 200 hits had homology to
uncharacterized mitochondrion DNA, possibly suggesting that HspB2 plays an intimate role with
an inner mitochondrial protein. This association may help explain the ATP defects in muscle
cells found in HspB2 knockout mice. In addition, the HspB2 association with proteins involved
in apoptosis such as cytochrome C and GAPDH may help explain the anti-apoptoic properties of
cells overexpressing HspB2.
N o mitochondrial chaperone has been reported however it seems likely since large quantities of
reactive oxygen species are produced inside the mitochondria. This study shows that HspB2
associates with Gpx3 and Txnip, proteins known to neutralize hydrogen peroxide and other
harmful species in the heart. Ischemia followed by reperfusion is a time of particular ROS
generation, and it makes sense that mitochondria would be damaged to the point that energy
production decreases due to a result of misfolded proteins, as may occur during this time of
stress. This could, in part, explain previous findings as discussed in chapter one regarding ATP
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production in KO mice.9, 10 In addition, it could help explain the previous finding that
glutathione levels are greatly affected in mice harboring mutant CryAB.11
As stated previously, HspB2 dependency tests offer an additional level of confidence in our yeast
two-hybrid results. The HspB2 tests conducted by this study report confident interactions
between HspB2 and 28 proteins hit by our yeast two-hybrid screen.
Perhaps one of the most intriguing findings of this study is that HspB2 binds CryAB both in
yeast and mammalian cells. One of the reasons HSPB2 was chosen for a yeast two-hybrid study
was because of its relation to CRYAB as well as the fact that it was detected in a previous yeast
two-hybrid screen using R120G CRYAB as bait (Julianne Grose, unpublished results)., a mutant
CryAB that confers cardiomyopathy in mice and man. As presented in Chapter One, HSPB2 and
CRYAB share regulatory elements because of their proximity to each other on chromosome 11
and share high amino acid conservation. Thus our verification of a CryAB/HspB2 interaction
confirms a close relationship between these proteins.
This study shows that HspB2 is involved in multiple cellular processes. As a small heat shock
protein, HspB2 serves to confer stress resistance to the cell and may work closely with other
well-studied sHSPs such as CryAB. Particularly prevalent are the putative interactions between
HspB2 and muscle and mitochondrial proteins which may help elucidate the mechanisms by
which HspB2 affects muscle ATP levels and apoptosis. Further research will be necessary to
perform co-immunoprecipitation analysis with the rest of our “high confidence” hits. As part of
a larger study protein-protein interaction study composed of several other sHSPs known to be
involved in cardiomyopathy, these results may also lead to a deeper understanding of the role of
individual heat shock proteins as well as the amount of redundancy within the family. By
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constructing a protein interaction network we hope to better understand the mechanism of
disease of cardiomyopathy in addition to basic muscle regulation and maintenance.
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APPENDIX A: Protocols—In order of application
Y2H Mating (120X screen) (see also MatchmakerTM Gold Yeast Two-Hybrid User Manual)

Before starting, make sure:
a) Plate of bait-Y2H Gold is freshly streaked (<1month in fridge)
b) Enough plates have been poured (SD–leu–trp–his–ade) (~50 big plates 150 x 15mm)
Steps:
1.
2.
3.
4.
5.
6.
7.
8.
9.

Grow up 50mL O/N of bait in SD-Trp
Pellet and re-suspend in 50 mL 2x YPAD with 166.7 L kanamycin
Add to flask along with 1mL of yeast library (thaw library at room temp before adding)
Slow shake (RPM 40) for 24 hours
Pellet 1,000 x g for 10 minutes
Rinse Flask with 50 Ml 0.5xYPAD and use to re-suspend pellet
Pellet 1,000 x g for 10 minutes
Remove supernatant and re-suspend in 10 mL 0.5x YPAD
Make dilution series to test mating efficiency starting with 100 uL of mating mix (1/10,
1/100, 1/1,000, 1/10,000)
10. Plate out each dilution on to SD –leu, SD –trp, and SD –leu-trp plates
11. Plate the rest of yeast cells onto SD-leu-trp +Auerobasidin
12. Incubate in 30o incubator (dilution plates 2-3 days, screen plates ~ 7 days)
13. Count and Record dilution on plates to determine # of matings
14. Colonies that grow up on screen plates, continue on to patching protocol

Y2H Patching
Before starting make sure:
a) Have plates to patch on (SD –leu – trp – his –ade)
b) Have autoclaved toothpicks
Steps:
1. Make sure to use sterile technique and have a flame on.
2. With a sterile toothpick, pick colony from transformation/mating plate (SD –leu – trp –
his –ade) and patch to appropriate plate.
3. Incubate at 30o C for ~2 days or until colonies have grown up
4. Number each colony that grow up and record these as # of putative interactors.
5. Record Strength of interactions (i.e. S=strong, M=medium, W=weak, VW=very
weak).
Lyticase (To lyticase yeast colony to prep for use as template DNA for PCR)
1. Combine in a pre-labeled PCR tube the following:
a. 10μL 0.5M Tris-HCl (pH. 7.5)
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2.
3.
4.
5.
6.

b. 5μL lyticase
Use a pipet tip to gently scrape some of a colony from the 91-grid plate and swish into
the solution in the corresponding PCR tube. The solution should now be turbid.
Vortex the PCR tube.
Incubate tubes at 37OC with shaking for 30 min.
Boil at 95-100OC for 5 min.
Freeze samples at -20OC or use immediately in PCR reaction. If using as template DNA
for PCR reaction, spinning the tubes in a

PCR
**Note that we used various primers ing the prey plasmid Gal4 activation domain
(forward primter) as well as the terminator region (reverse primer) to optimize the PCR
reaction**
1. Make master mix for the number of lyticase samples plus a negative control.
Mix (For one 25μL sample):
a. 18.55μL ddH2O
b. 2.63μL NEB Thermopol buffer (New England Biolabs, Inc., Cat. No. B9004S)
c. 0.79μL 10mM dNTPs
d. 0.4μL forward primer
e. 0.4μL reverse primer
f. After mixing the reagents above, add .25μL Taq DNA polymerase (New England
Biolabs, Inc., Cat. No. M0267X)
2. Place 2μL template DNA (to lyse yeast to get template DNA from 91-grid plate see
Lyticase Protocol) into pre-labeled tube. Note that if you are using template from
lyticase protocol of yeast it will be very dirty and must be kept on ice to avoid
degradation.
3. Aliquot 23μL into each PCR tube containing template DNA.
4. Cap PCR tubes and place in thermocycler asap.
a. Thermocycler program times depend on primer.
Plasmid Isolation from Yeast (For transforming plasmid into E. coli)
*Denotes points at which you can stop if you do not have time for the entire protocol.
1. Pick a colony from 91-grid plate and inoculate into 5mL SD-Leu (for prey plasmid
isolation) or appropriate media for proper plasmid isolation
2. Vortex for 1 min. Leave to grow for ~3 days at 30OC.
3. Spin yeast culture at 13,000rpm for 2 min. in 1.5-2.0mL. Discard supernatant. Repeat
until all 5mL are spun down.
4. *Pour off supernate and resuspend the pellet in residual liquid (i.e. do not spin tube and
remove all liquid).
5. Add 20μL of 0.5M Tris-HCl (pH 7.5). Mix thoroughly by vortexing/pipetting.
6. Add 10μL lyticase. Mix thoroughly by vortexing/popetting.
7. Incubate samples form 30-60 min. at 37OC in shaker.
8. Add 20μL of 10% SDS and vortex for 1 min.
9. *Freeze samples at -20OC. This usually takes ~15 mins.
10. Thaw at room temperature, but don’t let them sit out too long or DNA will degrade.
11. Vortex.
12. Start Sigma-Aldrich GenElute™ Plasmid Miniprep Kit (Sigma, Cat. No. PLN350-1KT)
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13. *Freeze yeast plasmid prep at this point or continue to transform into E. coli.
Making E. coli Plasmid Prep from Yeast Plasmid Transformation:
Steps:
1. Inoculate a colony from transformation plate into 5 mL selective media (LB+AMP)
2. Place in 37o C shaker for 24 hours
3. Spin down at 13,000 rpm for 1 minute to pellet. Remove supernatant. Repeat until all 5
mL is spun down.
4. *You can freeze at this point or continue on to the next step
5. Start SIGMA miniprep kit at step 1 (re-suspend in 200 L re-suspension buffer).
Continue through rest of steps.
6. Check concentration/quality of your prep. You should have at least 100 ng/L and a
sharp clean peak at 260.
7. Place E. coli plasmid prep in appropriate box in -20oC freezer for dependency tests to be
performed.
Transformation for DH5α E. coli
Steps:
1. Retrieve DH5α cells from -80OC freezer and place immediately on ice.
2. Allow cells to thaw on ice for a few minutes.
3. Add 2-5μL of plasmid prep to 25μL DH5α. Keep on ice for 2-30 min.
4. Heat shock for 1 min. at 42OC.
5. Place tube immediately back into the ice bucket to cool for 2-5 min.
6. Add 500μL LB and incubate at 37o C for 30 minutes (if selection is AMP)
7. Plate on selective media (i.e. LB+AMP) and incubate for 24 hours at 37o C.
8. *Place plate with colonies in fridge until ready to grow up an overnight for an E.coli
plasmid prep.
Transfection and Coimmunoprecipitation
Guidelines for Transfection
 Maintain same seeding conditions between experiments
 Use low-passage cells; make sure they are healthy and more than 90% viable before
transfection
 Can be performed with or without serum media
 Opti-MEM I Reduced Serum Medium (Cat. No. 31985-070) to dilute DNA
Lipofectamine LTX reagent before complexing.
Following Reagents Necessary
 HEK 293 cells in DMEM (Cat. No. 11960-044) supplemented with 4mM L-Glutamine
(Cat. No. 25030-081), 10% fetal bovine serum (Cat. No. 16000-044).
 Plasmid DNA of interest
 Lipofectamine LTX Reagent
 Opti-MEM I Reduced Serum Media (Cat. No. 31985-070)
 Tissue Culture Plates and Supplies
o Phosphate-buffered saline (PBS)
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DAY 1
Transfection Protocol
1. The day before transfection, trypsinize and count the cells. Plate 6.25 x 105 cells per well
in 2.0 ml of complete growth medium. Cell density should be 50-80% confluent on day
of transfection.
2. (Optional) The day of transfection, remove growth medium from cells and replace with
2.0 ml of complete growth medium.
3. For a six-well transfection: dilute 2.5μg DNA into 500μl Opti-MEM Reduced Serum
Media without serum.
4. Add 3.75-8.75μl Lipofectamine LTX Reagent to the diluted Opti-MEM:DNA solution (6
uL is the standard), mix gently and incubate 30 min at room temperature to form DNALipofectamine LTX Reagent complexes.
5. After 30 minute incubation, add 500 μl of the DNA-Lipofectamine LTX Reagent
complexes directly to each well containing cells and mix gently by rocking the plate back
and forth.
6. Complexes do not have to be removed following transfection. Incubate the cells at 37oC
in a CO2 incubator for 48 hours post-transfection performing copurification or expression
experiments.
DAY 3
Coaffinity Purification Experiments in HEK 293T Cells
a) Aspirate off media and wash 1 time with cold 1x PBS (2 ml per well of 6 well plate)
b) Add 0.5 ml (0.5% NP-40, 20mM Tris-HCl [pH 8.0],180mM NaCl, 1mM EDTA, and
complete protease inhibitor cocktail [Roche]) for 15min on ice. Place on ice for 20-30
minutes with occasional shaking. Collect cells into a 1.5 ml tube using p1000 pipetman.
After complete lysis, no cells should be left on the plate.
c) Continue to rotate in fridge for 10 minutes.
d) Centrifuge for 15min at 13,000rpm at 4oC.
e) Take out supernate and transfer to a new tube that has been chilled on ice.
f) Take out 50 μL and add 12 μL of 5X SDS-buffer. Boil 5 minutes. Store in freezer for
later (this is the lysate control to check for gene expression).
g) Add anti-myc antibody to the remaining 0.45 mL. Incubate overnight at 4OC while
rotating.
DAY 4
h) Add 20 μL of protein G beads that have been washed and equilibrated. Be sure to cut-off
the yellow tip of the pipet to be sure it pipets easily. Rotate at 4oC for 1.5 hr, then
centrifuge at 4oC at 2000 rpm for 3 minutes to pellet beads.
a. Washing and equilibrating protein G beads.
i. Resuspend beads well by inverting. Pipet out the desired volume and
mark the side of the eppendorf with a marker to indicate the volume.
Centrifuge at 2000 rpm / 3 minutes at 4OC, then carefully remove
supernatant with needle and syringe. Replace with 1 mL water and repeat
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centrifugation and aspiration. Resuspend in 1 mL NP-40 lysis buffer.
Repeat centrifugation, aspiration, and resuspension in buffer but this time
add buffer to the mark on the eppendorf so the volume is the original
volume.
ii. ****Do not centrifuge protein G beads above 2000rpm****
i) Wash 2x with 1 mL cold lysis NP-40 buffer without proteases. Each time centrifuge at
2000 rpm for 3 minutes in the cold room or fridge, then carefully remove supernatant
with needle and syringe.
j) Remove lysis buffer after third wash.
k) Add 30 μL of 4x sample loading buffer. Boil 5 min. Spin down 30 seconds. Keep on
ice/fridge/freezer until western run with anti-myc and anti-HA antibodies as well as the
lysate controls!
Buffers:
a. NP-40 Lysis buffer:
88.5 ml H2O
(to final volume 100 ml)
5 ml 1 M Tris-HCl (pH 7.5) to final concentration 50 mM
5 ml 3 M NaCl
to final concentration 150 mM
0.5 ml NP-40
to final concentration 0.5%
0.21 g NaF
to final concentration 50 mM
b. Before use add to each 1 ml of lysis buffer (always add PMSF last):
10 µL 0.1 M Na3VO4
to final concentration 1 mM
10 µL 0.1 M DTT
to final concentration 1 mM
10 µL 100x protease inhibitor to final concentration 1x
10 µL 100 mM PMSF
to final concentration 1 mM
Western Blotting
I. Materials
 Transfer buffer: 4L = 57.64g glycine; 12.12g Tris base; 800ml Methanol; ddH2O to 4
liters. Store at 4C. Recycle 5 times.
 TBS (1x): (20 mM Tris, 500 mM NaCl)
2L = 4.84g Tris; 58.48g NaCl; ddH2O to 2 liters adjust pH to 7.5 with conc. HCl.
 TTBS: 1L = 0.5ml of Tween-20 to 1 liter of TBS
 Blocking buffer: 50ml of TBS with 5% dry milk
 Antibody buffer: make up 10ml – antibodies are expensive so use as little as possible.
Antibody solutions can be saved in the fridge for ~1 month and reused.
o Primary: use as per manufacturer’s instructions. This is usually a 1:500 dilution
in 1x TBST with 1% BSA.
o Secondary: Use either anti-rabbit or anti-mouse depending on primary antibody.
Secondary antibodies are usually used at a 1:10,000 dilution in TBST with 1% dry
milk.
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HRP color development solution: Mix together equal amounts of the reagents right
before use. DO NOT MIX EITHER REAGENT INTO THE STOCK VIALS!
Stripping Buffer: 67.5mM Tris. Cl pH 6.7; 2% SDS; 100mM -ME

II. Method
1. Prepare samples for gel. See preparation of yeast cells for western blotting if necessary.
Prepare protein MW markers for gel by boiling the desired amount to be loaded in gel.
2. Pour a SDS-PAGE gel.
3. Western Blot: With gloves, carefully measure and cut nitrocellulose rectangles the size of
the western blot sponges. Pour transfer buffer into a large Tupperware tray. Slip one
rectangle of nitrocellulose in at a 45 angle. Leave for a few minutes.
4. Open up glass plates of SDS-PAGE gel. Remove stacking gel by scraping off. Carefully
bind a rectangle of 3mm paper on top. Roll out air bubbles gently with a plastic pipette. Wet
sponges in transfer buffer and put one under and one over the sandwich. Roll out the air
bubbles gently. Place sandwich in plastic “cage” with black side on gel side.

5. Set up Western blot apparatus with stir bar inside and ~1/2 full of transfer buffer. Put ice
block (or water cooler for large transfer) and sandwich cage(s) inside electrode box. When
it’s all set up, the transfer buffer should be at the top of the chamber. Place on stir plate and
stir rapidly. Set amperage at < 500 mA. As the temperature increases, amperage will
increase and the power supply will buzz if it goes over 500mA. Transfer for 1.5 hours. (If
using the 200/2.0 power supply, run mini-blot at 300V or full size blot at 800mA.) Be
careful – high amperage kills!
6. Open up sandwich and check that all visible markers have transferred to the nitrocellulose.
7. Wearing gloves put nitrocellulose in 50 ml blocking buffer and shake for 30 minutes. Pour
out blocking buffer. Rinse blot once with TTBS.
8. Put nitrocellulose into primary (1) Ab buffer. Incubate with shaking for 2 hours ->
overnight.
9. Wash blot 3 times with TTBS for 10 minutes each.
10. Soak blot in 10mls of antibody buffer + secondary (2) Ab. Incubate 1 hour.
11. Wash blot 3 times in TTBS for 10 minutes each. Then wash once in TBS. Pour off TBS
and add color development solution made immediately prior to using. Quickly blot off
nitrocellulose paper (NP) on paper towel. Then incubate NP in reaction mix for 1-2 min (up
to 10 if you suspect a low signal). Then blot off and wrap in syran wrap, tape into cassette.
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Expose on film. There should be bands forming within 1 minute. Once bands are clearly
visible, rinse blot with water, dry and photograph, if desired.
Note: If you need to strip and reprobe use ~20-30ml Stripping buffer. Incubate at 50 for 30
minutes. Rinse, blot well, and reprobe.
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